RecentMedicalFindings.com
Summarizing relevant biomedical research!
leukocytosis     Bookmark and Share
Search webpages of this site (RecentMedicalFindings):
Didn't find what you wanted? Try it at BioMedLib™ !
Search directly on the biomedical articles using BioMedLib™ search engine:



1. Biomedical articles (top 50; 2009 to 2014)
1. |||||||||. 100%  George TI: Malignant or benign leukocytosis. Hematology Am Soc Hematol Educ Program; 2012;2012:475-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant or benign leukocytosis.
  • Leukocytosis, or elevated WBC count, is a commonly encountered laboratory finding.
  • Distinguishing malignant from benign leukocytosis is a critical step in the care of a patient, which initiates a vastly different decision tree.
  • Confirmation of the complete blood cell count and the WBC differential is the first step.
  • Examination of the PB smear is essential to confirming the automated blood cell differential or affirming the manual differential performed on the PB smear.
  • Next is separation of the leukocytosis into a myeloid versus a lymphoid process.
  • Distinguishing a reactive lymphoid proliferation from a lymphoproliferative disorder requires examination of lymphocyte morphology for pleomorphic lymphocytes versus a monomorphic population, with the latter favoring a lymphoproliferative neoplasm.
  • Myeloid leukocytosis triggers a differential diagnosis of myeloid leukemoid reactions versus myeloid malignancies.
  • Myeloid leukemoid reactions commonly result from infections and show activated neutrophil changes on morphology; these should prompt evaluation for infection.
  • Other causes of reactive myeloid leukocytoses are also discussed herein.
  • [MeSH-major] Cell Count / methods. Hematology / methods. Leukocytosis / diagnosis. Leukocytosis / therapy
  • [MeSH-minor] Algorithms. Automation. Bone Marrow Cells / cytology. Cell Proliferation. Cell Separation. Diagnosis, Differential. Flow Cytometry / methods. Humans. Leukemia, Myeloid / therapy. Leukemoid Reaction. Leukocyte Count. Leukocytes / cytology. Lymphocytes / cytology. Lymphoproliferative Disorders / blood. Lymphoproliferative Disorders / therapy. Myeloproliferative Disorders / diagnosis

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23233622.001).
  • [ISSN] 1520-4383
  • [Journal-full-title] Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
  • [ISO-abbreviation] Hematology Am Soc Hematol Educ Program
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


2. ||||||||.. 78%  Grant R, Youm YH, Ravussin A, Dixit VD: Quantification of adipose tissue leukocytosis in obesity. Methods Mol Biol; 2013;1040:195-209
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quantification of adipose tissue leukocytosis in obesity.
  • The infiltration of immune cell subsets in adipose tissue termed "adipose tissue leukocytosis" is a critical event in the development of chronic inflammation and obesity-associated comorbidities.
  • Given that a significant proportion of cells in adipose tissue of obese patients are of hematopoietic lineage, the distinct adipose depots represent an uncharacterized immunological organ that can impact metabolic functions.
  • Here, we describe approaches to characterize and isolate leukocytes from the complex adipose tissue microenvironment, to aid mechanistic studies to better understand the role of specific pattern recognition receptors (PRRs) such as inflammasomes in adipose-immune cross talk.
  • [MeSH-major] Adipose Tissue / pathology. Leukocytosis / diagnosis. Obesity / pathology
  • [MeSH-minor] Animals. Flow Cytometry. Humans. Immunophenotyping. Intra-Abdominal Fat / pathology. Leukocytes / cytology. Leukocytes / metabolism. Mice

  • Genetic Alliance. consumer health - Obesity.
  • MedlinePlus Health Information. consumer health - Obesity.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2003 Dec;112(12):1796-808 [14679176.001]
  • [Cites] Am J Clin Nutr. 2006 Feb;83(2):461S-465S [16470013.001]
  • [Cites] J Clin Invest. 2007 Jan;117(1):175-84 [17200717.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E166-74 [16926380.001]
  • [Cites] Curr Opin Immunol. 2007 Dec;19(6):615-22 [17977705.001]
  • [Cites] Int J Obes (Lond). 2008 Mar;32(3):451-63 [17895881.001]
  • [Cites] J Lipid Res. 2008 Sep;49(9):1894-903 [18503031.001]
  • [Cites] Nat Med. 2009 Aug;15(8):940-5 [19633655.001]
  • [Cites] Nat Med. 2009 Aug;15(8):914-20 [19633658.001]
  • [Cites] J Immunol. 2010 Aug 1;185(3):1836-45 [20581149.001]
  • [Cites] Endocrinology. 2010 Sep;151(9):4247-56 [20660063.001]
  • [Cites] Obesity (Silver Spring). 2010 Oct;18(10):1918-25 [20111012.001]
  • [Cites] Cell Metab. 2010 Dec 1;12(6):593-605 [21109192.001]
  • [Cites] Nat Med. 2011 Feb;17(2):179-88 [21217695.001]
  • [Cites] Nat Med. 2011 May;17(5):610-7 [21499269.001]
  • [Cites] Cell Rep. 2012 Jan 26;1(1):56-68 [22832107.001]
  • (PMID = 23852606.001).
  • [ISSN] 1940-6029
  • [Journal-full-title] Methods in molecular biology (Clifton, N.J.)
  • [ISO-abbreviation] Methods Mol. Biol.
  • [Language] eng
  • [Grant] United States / NIGMS NIH HHS / GM / 8P20 GM103528; United States / NIA NIH HHS / AG / AG31797; United States / NIDDK NIH HHS / DK / DK090556; United States / NIGMS NIH HHS / GM / P20 GM103528; United States / NIDDK NIH HHS / DK / P30 DK072476; United States / NIDDK NIH HHS / DK / P30 DK072476; United States / NIA NIH HHS / AG / R01 AG031797; United States / NIDDK NIH HHS / DK / R01 DK090556; United States / NIDDK NIH HHS / DK / T32 DK064584; United States / NIDDK NIH HHS / DK / T32DK064584-10S1
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS567491; NLM/ PMC3972009
  •  go-up   go-down


3. ||||||.... 64%  Furer V, Raveh D, Picard E, Goldberg S, Izbicki G: Absence of leukocytosis in bacteraemic pneumococcal pneumonia. Prim Care Respir J; 2011 Sep;20(3):276-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Absence of leukocytosis in bacteraemic pneumococcal pneumonia.
  • BACKGROUND: Evaluation of patients with respiratory symptoms in primary care medicine is often based on peripheral WBC count that dictates the extent of diagnostic investigation.
  • A normal WBC count may result in a limited investigation, often omitting chest radiography.
  • AIMS: To determine the extent to which patients hospitalised with bacteraemic pneumococcal pneumonia have no leukocytosis at presentation.
  • RESULTS: 21% of the patients presented with a normal WBC count (16.7% of the children and 25.6% of the adults).
  • Among this population with a normal WBC count at presentation, 90% of the adults and 70% of the children developed leukocytosis within a few days after admission.
  • CONCLUSIONS: In this study, in as many as one-fifth of all the patients with bacteraemic pneumococcal pneumonia, there was no leukocytosis at presentation.
  • We therefore suggest that every patient with clinically suspected pneumonia should undergo chest radiography even if the WBC count is normal.
  • [MeSH-major] Bacteremia / blood. Bacteremia / diagnosis. Pneumonia, Pneumococcal / blood. Pneumonia, Pneumococcal / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Community-Acquired Infections / blood. Community-Acquired Infections / complications. Female. Humans. Infant. Leukocytosis / complications. Leukocytosis / epidemiology. Male. Middle Aged. Retrospective Studies. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21509416.001).
  • [ISSN] 1475-1534
  • [Journal-full-title] Primary care respiratory journal : journal of the General Practice Airways Group
  • [ISO-abbreviation] Prim Care Respir J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


Advertisement
4. |||||..... 54%  Richards JR, Farias VF, Clingan CS: Association of leukocytosis with amphetamine and cocaine use. ScientificWorldJournal; 2014;2014:207651
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of leukocytosis with amphetamine and cocaine use.
  • OBJECTIVE: Determining the etiology of unexplained leukocytosis in asymptomatic patients may incur unnecessary testing, cost, and prolonged emergency department stay.
  • RESULTS: With a total of 1,206 patients, 877 (72.7%) amphetamines/cocaine-negative drug screen controls had mean WBC 8.4 ± 2.6 × 10³/µL.
  • The 240 (19.9%) amphetamines-positive, cocaine-negative, patients had WBC 9.4 ± 3.3 × 10³/µL (P < 0.0001).
  • The 72 (6.0%) amphetamines-negative, cocaine-positive, patients had WBC 7.1 ± 1.8 × 10³/µL (P < 0.0001).
  • The remaining 17 (1.4%) amphetamines/cocaine-positive patients had WBC 10.0 ± 4.2 × 10³/µL (P = 0.01).
  • Amphetamines-positive patients had a supranormal WBC ratio significantly higher than controls (23.8% versus 14.8%, P = 0.001), whereas only one cocaine-positive patient had a supranormal WBC count, with significantly lower ratio (1.4%, P = 0.0003).
  • CONCLUSION: Use of amphetamines, not cocaine, may be associated with idiopathic leukocytosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Immunopharmacol Immunotoxicol. 1994 Feb;16(1):1-21 [8169319.001]
  • [Cites] Ther Hung. 1992;40(2):51-7 [1462276.001]
  • [Cites] J Psychiatr Res. 1995 Mar-Apr;29(2):141-52 [7666381.001]
  • [Cites] Biol Psychiatry. 1995 Dec 1;38(11):751-5 [8580229.001]
  • [Cites] Brain Behav Immun. 1996 Jun;10(2):77-91 [8811932.001]
  • [Cites] Cell Immunol. 1996 Sep 15;172(2):217-23 [8964083.001]
  • [Cites] Life Sci. 1997;61(10):967-76 [9296335.001]
  • [Cites] Life Sci. 1997;61(24):PL 361-71 [9399637.001]
  • [Cites] Life Sci. 1998;62(21):PL 335-44 [9619850.001]
  • [Cites] Circulation. 1998 Nov 24;98(21):2307-13 [9826319.001]
  • [Cites] West J Med. 1999 Apr;170(4):198-202 [10344172.001]
  • [Cites] Neuroscience. 1999;92(1):343-52 [10392855.001]
  • [Cites] Int J Immunopharmacol. 1999 Jul;21(7):463-72 [10454020.001]
  • [Cites] J Neuroimmunol. 2005 Dec;169(1-2):161-71 [16150496.001]
  • [Cites] J Immunol. 2006 Jan 15;176(2):848-56 [16393968.001]
  • [Cites] J Neuroimmunol. 2006 Apr;173(1-2):180-7 [16376996.001]
  • [Cites] Exp Anim. 2006 Oct;55(5):477-81 [17090965.001]
  • [Cites] J Pharmacol Exp Ther. 2007 Feb;320(2):507-15 [17068203.001]
  • [Cites] J Physiol Pharmacol. 2006 Nov;57 Suppl 11:125-32 [17244944.001]
  • [Cites] Am J Addict. 2008 Jan-Feb;17(1):24-7 [18214719.001]
  • [Cites] J Neurosci. 2008 May 28;28(22):5756-61 [18509037.001]
  • [Cites] J Pharmacol Sci. 2008 Aug;107(4):361-9 [18719314.001]
  • [Cites] J Physiol Biochem. 2009 Mar;65(1):61-9 [19588732.001]
  • [Cites] Brain Behav Immun. 2003 Aug;17(4):251-9 [12831827.001]
  • [Cites] Auton Autacoid Pharmacol. 2003 Feb;23(1):1-25 [14565534.001]
  • [Cites] J Neuroimmunol. 2004 Feb;147(1-2):95-8 [14741436.001]
  • [Cites] J Pharmacol Exp Ther. 2004 Oct;311(1):1-7 [15163680.001]
  • [Cites] FASEB J. 2004 Oct;18(13):1600-2 [15319371.001]
  • [Cites] J Neuroimmunol. 2004 Nov;156(1-2):153-62 [15465606.001]
  • [Cites] Postgrad Med. 1983 Feb;73(2):113-5, 118-20, 123 [6823452.001]
  • [Cites] J Pharmacol Exp Ther. 1988 Sep;246(3):1048-52 [3047364.001]
  • [Cites] Neuropsychopharmacology. 1991 Aug;5(1):23-31 [1657016.001]
  • [Cites] J Neuroimmunol. 2000 Jan 24;102(2):113-24 [10636479.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2954-60 [11087252.001]
  • [Cites] Int Immunopharmacol. 2001 Apr;1(4):665-75 [11357879.001]
  • [Cites] Eur J Immunol. 2001 Dec;31(12):3504-12 [11745370.001]
  • [Cites] Ann N Y Acad Sci. 2002 Jun;966:20-7 [12114255.001]
  • [Cites] J Neuroimmunol. 2002 Nov;132(1-2):34-40 [12417431.001]
  • [Cites] Brain Behav Immun. 2010 May;24(4):525-8 [19896530.001]
  • [Cites] Neurol Res. 2009 Sep;31(7):687-91 [19061540.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Mar;88(3):1188-93 [12629105.001]
  • [Cites] Clin Toxicol (Phila). 2010 Aug;48(7):675-94 [20849327.001]
  • [Cites] Circulation. 2010 Dec 14;122(24):2558-69 [21156654.001]
  • [Cites] Hum Psychopharmacol. 2012 Mar;27(2):156-66 [22389080.001]
  • [Cites] PLoS One. 2012;7(3):e33822 [22479453.001]
  • [Cites] J Emerg Med. 2012 Nov;43(5):829-35 [22698827.001]
  • [Cites] Neurotox Res. 2013 Feb;23(2):174-88 [22714667.001]
  • [Cites] J Neurosci. 2013 May 22;33(21):8923-5 [23699503.001]
  • [Cites] Pharmacol Ther. 2013 Aug;139(2):289-300 [23631821.001]
  • [Cites] Top Companion Anim Med. 2013 Feb;28(1):2-7 [23796480.001]
  • [Cites] J Emerg Med. 2013 Jul;45(1):136-42 [23561310.001]
  • [Cites] Arch Gen Psychiatry. 1995 Aug;52(8):668-72 [7632120.001]
  • (PMID = 24578625.001).
  • [ISSN] 1537-744X
  • [Journal-full-title] TheScientificWorldJournal
  • [ISO-abbreviation] ScientificWorldJournal
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3919105
  •  go-up   go-down


5. |||||..... 54%  Tossige-Gomes R, Ottone VO, Oliveira PN, Viana DJ, Araújo TL, Gripp FJ, Rocha-Vieira E: Leukocytosis, muscle damage and increased lymphocyte proliferative response after an adventure sprint race. Braz J Med Biol Res; 2014 Jun;47(6):492-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukocytosis, muscle damage and increased lymphocyte proliferative response after an adventure sprint race.
  • The effect of an adventure sprint race (ASR) on T-cell proliferation, leukocyte count and muscle damage was evaluated.
  • The race induced a strong leukocytosis (6.22±2.04×10(3) cells/mm3 before vs 14.81±3.53×10(3) cells/mm3 after the race), marked by a significant increase of neutrophils and monocytes (P<0.05), but not total lymphocytes, CD3+ CD4+ or CD3+ CD8+ cells.
  • However, the T-cell proliferative response to mitogenic stimulation was increased (P=0.025) after the race, which contradicted our hypothesis that ASR, as a high-demand competition, would inhibit T-cell proliferation.
  • Muscle damage was evident after the race by increased serum levels of aspartate amino transferase (24.99±8.30 vs 50.61±15.76 U/L, P=0.003).

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Exp Immunol. 1978 May;32(2):339-45 [668205.001]
  • [Cites] Yale J Biol Med. 1980 Jul-Aug;53(4):275-9 [7445533.001]
  • [Cites] J Immunol Methods. 1981;40(1):115-6 [7204999.001]
  • [Cites] Eur J Appl Physiol Occup Physiol. 1982;48(1):41-9 [7199452.001]
  • [Cites] S Afr Med J. 1983 Oct 1;64(15):582-4 [6623247.001]
  • [Cites] J Appl Physiol (1985). 1986 Dec;61(6):2218-23 [3804928.001]
  • [Cites] Int J Sports Med. 1987 Feb;8(1):19-25 [3557778.001]
  • [Cites] Sports Med. 1988 Dec;6(6):333-63 [3068772.001]
  • [Cites] J Sports Med Phys Fitness. 1990 Sep;30(3):316-28 [2266764.001]
  • [Cites] J Appl Physiol (1985). 1991 Jan;70(1):179-85 [2010374.001]
  • [Cites] Int J Sports Med. 1994 Feb;15(2):100-4 [8157368.001]
  • [Cites] Med Sci Sports Exerc. 1994 Feb;26(2):128-39 [8164529.001]
  • [Cites] J Exp Med. 1995 Nov 1;182(5):1357-67 [7595206.001]
  • [Cites] Eur J Appl Physiol Occup Physiol. 1996;74(5):428-34 [8954290.001]
  • [Cites] BMJ. 1997 Apr 5;314(7086):1023-5 [9112849.001]
  • [Cites] J Physiol. 1997 Mar 15;499 ( Pt 3):833-41 [9130176.001]
  • [Cites] Cytometry. 1998 Jun 15;34(3):143-51 [9696158.001]
  • [Cites] Biochem Biophys Res Commun. 1998 Aug 19;249(2):366-70 [9712702.001]
  • [Cites] J Physiol. 1999 Feb 15;515 ( Pt 1):287-91 [9925898.001]
  • [Cites] Eur J Immunol. 2005 Nov;35(11):3163-72 [16245362.001]
  • [Cites] Exerc Immunol Rev. 2005;11:46-52 [16385843.001]
  • [Cites] Cytokine. 2007 Nov;40(2):75-81 [17919919.001]
  • [Cites] Exerc Immunol Rev. 2007;13:6-14 [18198657.001]
  • [Cites] J Sports Sci. 2008 Mar;26(5):477-89 [18274945.001]
  • [Cites] Blood. 2009 Mar 26;113(13):3008-16 [19018093.001]
  • [Cites] Scand J Clin Lab Invest. 2008;68(7):667-72 [18609111.001]
  • [Cites] Eur J Appl Physiol. 2010 Jun;109(3):447-53 [20143084.001]
  • [Cites] Eur J Immunol. 2010 Jun;40(6):1541-4 [20468008.001]
  • [Cites] Med Sci Sports Exerc. 2009 Oct;41(10):1896-901 [19727024.001]
  • [Cites] Braz J Med Biol Res. 2012 Dec;45(12):1262-8 [22948377.001]
  • [Cites] Exerc Immunol Rev. 2000;6:102-20 [10919064.001]
  • [Cites] Methods Cell Biol. 2001;63:375-98 [11060850.001]
  • [Cites] Am J Clin Pathol. 2002 Dec;118(6):856-63 [12472278.001]
  • [Cites] Clin Sci (Lond). 2003 Jan;104(1):69-77 [12519089.001]
  • [Cites] Med Sci Sports Exerc. 2003 Feb;35(2):348-55 [12569227.001]
  • [Cites] Br J Nutr. 2004 Jan;91(1):161-8 [14748950.001]
  • [Cites] J Emerg Med. 2004 Aug;27(2):161-5 [15261359.001]
  • [Cites] Scand J Haematol. 1975 Mar;14(1):5-10 [1121646.001]
  • (PMID = 24676476.001).
  • [ISSN] 1414-431X
  • [Journal-full-title] Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.]
  • [ISO-abbreviation] Braz. J. Med. Biol. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  • [Other-IDs] NLM/ PMC4086176
  •  go-up   go-down


6. |||||..... 53%  Asadollahi K, Hastings IM, Beeching NJ, Gill GV, Asadollahi P: Leukocytosis as an alarming sign for mortality in patients hospitalized in general wards. Iran J Med Sci; 2011 Mar;36(1):45-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukocytosis as an alarming sign for mortality in patients hospitalized in general wards.
  • There is some evidence that leukocytosis without infection is associated with increased hospital mortality, but data in this regard are very incomplete.
  • This study was designed to investigate the relationship between leukocytosis at the time of admission and mortality among patients hospitalized in general wards.
  • During July to Nov 2004, all deceased patients who had a white blood cell (WBC) count record for the first 24 hours of admission were selected as cases.
  • Among survivors, twice the number of cases was selected as controls.
  • Different levels of WBC counts were compared between cases and controls.
  • The median WBC for deceased and surviving patients was 9.4 and 11.4×10(9)/l, respectively.
  • Patients with a WBC >10×10(9)/l accounted for 804, among which 335 (42%) were deceased.
  • Leukocytosis and leukopoenia were more frequent among the deceased patients compared to the survivors.
  • The likelihood ratio for leukocytosis and leukopenia among the cases and controls was 1.4 and 2.3, respectively.
  • Leukocytosis was identified as an alarming sign for mortality among patients admitted to general hospital wards at early stages of admission.
  • A quick medical intervention for amendment of the causes related to leukocytosis should consequently reduce hospital mortality.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Coll Cardiol. 2001 Nov 15;38(6):1654-61 [11704377.001]
  • [Cites] Br Med J (Clin Res Ed). 1987 Sep 12;295(6599):636 [3117270.001]
  • [Cites] QJM. 2010 May;103(5):285-92 [20056764.001]
  • [Cites] Am J Med Sci. 1998 Apr;315(4):233-6 [9537636.001]
  • [Cites] Colorectal Dis. 2007 Feb;9(2):173-7 [17223943.001]
  • [Cites] Ann Intern Med. 1987 Jan;106(1):65-74 [3538968.001]
  • [Cites] Pediatr Int. 2008 Jun;50(3):281-3 [18533936.001]
  • [Cites] JOP. 2008;9(6):690-7 [18981549.001]
  • [Cites] Psychiatry Res. 1988 Sep;25(3):243-51 [3186859.001]
  • [Cites] Am J Cardiol. 2001 Mar 1;87(5):636-9, A10 [11230853.001]
  • [Cites] World J Surg. 2001 Jun;25(6):739-44 [11376409.001]
  • [Cites] QJM. 2007 Aug;100(8):501-7 [17609227.001]
  • (PMID = 23365478.001).
  • [ISSN] 0253-0716
  • [Journal-full-title] Iranian journal of medical sciences
  • [ISO-abbreviation] Iran J Med Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Iran
  • [Other-IDs] NLM/ PMC3559113
  • [Keywords] NOTNLM ; General hospital / hospital mortality / inpatient / leukocytosis
  •  go-up   go-down


7. |......... 5%  Cooper IF, Siadaty MS: 'Bacteriums' associated with 'Elevated Wbc Count': Top Publications. BioMedLib Review; Bacterium;ElevatedWbcCount:705595947. ISSN: 2331-5717. 2014/4/24
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Bacteriums' associated with 'Elevated Wbc Count': Top Publications.
  • Background: There are articles published each month which present 'bacterium' for 'elevated wbc count'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Wanahita A et al: Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile.
  • Bauer MP et al: Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis.
  • Anjay MA et al: Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection.
  • Vaitkevičienė G et al: High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies.
  • Lund MH: Leukocytosis in pharyngitis due to group A beta-hemolytic Streptococcus.
  • BLOBEL H et al: EFFECTS OF EXPERIMENTALLY INDUCED LEUKOCYTOSIS IN BOVINE MAMMARY GLANDS UPON INFECTIONS WITH STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS AGALACTIAE, AND AEROBACTER AEROGENES.
  • Ishida S et al: [Effects of heat-labile toxin of B. pertussis on mouse blood cells: the determination of LPF (leukocytosis-promoting factor)].
  • Wanahita A et al: Clostridium difficile infection in patients with unexplained leukocytosis.
  • Albrich WC et al: Clostridium difficile: association with thrombocytosis and leukocytosis.
  • Swartz SL et al: Persistent urethral leukocytosis and asymptomatic chlamydial urethritis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 705595947.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


8. |||||||||. 175%  Chabot-Richards DS, George TI: Leukocytosis. Int J Lab Hematol; 2014 Jun;36(3):279-88
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukocytosis.
  • An increased white blood cell count, or leukocytosis, is a common laboratory finding.
  • Appropriate specimen evaluation depends on which lineages are increased and the morphologic findings on peripheral blood smear review to guide further testing.
  • Myeloid leukocytosis can occur in a number of reactive conditions as well as myeloid malignancies.
  • The types of cells present and morphology can help to guide additional workup.
  • This study provides guidance for the appropriate evaluation and further workup of leukocytosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2014 John Wiley & Sons Ltd.
  • (PMID = 24750674.001).
  • [ISSN] 1751-553X
  • [Journal-full-title] International journal of laboratory hematology
  • [ISO-abbreviation] Int J Lab Hematol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Leukocytosis / lymphocytosis / lymphoma / morphology / neutrophilia
  •  go-up   go-down


9. |||||||||. 106%  Fonda P, de Santiago E, Guijarro M, Gamallo C: Mediastinal myelolipoma with leukocytosis. BMJ Case Rep; 2013;2013
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mediastinal myelolipoma with leukocytosis.
  • We report the case of a 64-year-old woman who presented a heterogeneous 1.4×2.5×3 cm paravertebral thoracic mass detected by chest tomography during the study of a leukocytosis of unknown aetiology.
  • The CT findings and pathology revealed the diagnosis of myelolipoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23813520.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


10. ||||||||.. 79%  Worley MJ Jr, Nitschmann CC, Shoni M, Vitonis AF, Rauh-Hain JA, Feltmate CM: The significance of preoperative leukocytosis in endometrial carcinoma. Gynecol Oncol; 2012 Jun;125(3):561-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The significance of preoperative leukocytosis in endometrial carcinoma.
  • OBJECTIVE: To evaluate the impact of preoperative leukocytosis among patients with endometrial carcinoma.
  • Patients were separated into two groups based on the presence or absence of preoperative leukocytosis (WBC ≥ 10,000 cells per μl).
  • RESULTS: 1144 patients were identified, 156 (13.6%) with preoperative leukocytosis and 988 (86.4%) without leukocytosis.
  • The leukocytosis group had a greater percentage of patients with stage 3 (15.4% vs. 9.8%, crude p=0.02) and 4 (7.1% vs. 3.0%, crude p=0.007) disease.
  • Leukocytosis was associated with a greater mean tumor size (4.4 vs. 3.4 cm, p=0.0002) and a greater percentage of patients with cervical stromal involvement (14.8% vs. 8.7%, crude p=0.02), adnexal involvement (14.1% vs. 7.5%, crude p=0.007) and lymphvascular space invasion (24% vs. 16.3%, crude p=0.02).
  • On multivariate analysis, mean tumor size (OR, 95% CI; 1.10, 1.02-1.18) remained significantly associated with preoperative leukocytosis.
  • However, leukocytosis was independently associated with an increased risk of death (HR, 95% CI; 1.69, 1.07-2.68).
  • CONCLUSIONS: Preoperative leukocytosis, among endometrial cancer patients, was independently associated with increasing tumor size and independently imposed an increased risk of death.
  • [MeSH-major] Endometrial Neoplasms / blood. Endometrial Neoplasms / surgery. Leukocytosis / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2012 Elsevier B.V. All rights reserved.
  • (PMID = 22465698.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. ||||||||.. 77%  Kuznik BI, Morozova IIu, Rodnina OS, Strambovskaia NN, Shirshov IuA: [Leukocytosis and outcomes of acute stroke]. Zh Nevrol Psikhiatr Im S S Korsakova; 2010;110(3):10-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Leukocytosis and outcomes of acute stroke].
  • We carried out the retrospective analysis of 300 disease histories of patients with stroke hospitalized in the first 24 h of the disease.
  • The presence of leukocytosis and its severity were evaluated as predictors of outcome.
  • The level of leukocyte-erythrocyte aggregations in the blood film was determined in some patients.
  • The analysis revealed that the higher was leukocytosis, the more severe was the course of stroke and the higher was frequency of fatal outcomes.
  • Patients with stroke more often had neutrophilic leukocytosis than monocytosis, the former was the predictor of worse prognosis.
  • The most unfavorable prognosis was observed in patients with hemorrhagic stroke and leukocytosis.
  • The higher was the number of leukocytes, the higher was the probability of fatal outcome in the first month of stroke.
  • The level of leukocyte-erythrocyte aggregations dramatically increased in the blood of stroke patients that promoted the disturbance of microcirculation and worsened significantly the disease prognosis.
  • [MeSH-major] Leukocytosis / blood. Leukocytosis / etiology. Stroke / blood. Stroke / mortality
  • [MeSH-minor] Female. Humans. Leukocyte Count. Male. Monocytes. Neutrophils. Prognosis. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Stroke.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20517219.001).
  • [ISSN] 1997-7298
  • [Journal-full-title] Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoĭ promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe obshchestvo nevrologov [i] Vserossiĭskoe obshchestvo psikhiatrov
  • [ISO-abbreviation] Zh Nevrol Psikhiatr Im S S Korsakova
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


12. |||||||... 67%  Sopko MA, Caley CF: Chronic leukocytosis associated with clozapine treatment. Clin Schizophr Relat Psychoses; 2010 Jul;4(2):141-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chronic leukocytosis associated with clozapine treatment.
  • Unfortunately, clozapine is also associated with a number of adverse effects, with agranulocytosis being one of the chief concerns.
  • Interestingly, patients who receive clozapine treatment may occasionally experience elevations in their total white blood cell count (WBC).
  • In some of these patients, the leukocytosis may be persistent.
  • We report the case of a patient with refractory schizophrenia who is treated with clozapine and who experienced chronic leukocytosis.
  • A brief review of the literature addressing clozapine-associated leukocytosis follows the case report.
  • [MeSH-major] Antipsychotic Agents / adverse effects. Clozapine / adverse effects. Leukocytosis / chemically induced. Schizophrenia, Paranoid / drug therapy
  • [MeSH-minor] Adult. Chronic Disease. Dose-Response Relationship, Drug. Drug Therapy, Combination. Humans. Leukocyte Count. Male

  • HSDB. structure - CLOZAPINE.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20643637.001).
  • [ISSN] 1935-1232
  • [Journal-full-title] Clinical schizophrenia & related psychoses
  • [ISO-abbreviation] Clin Schizophr Relat Psychoses
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antipsychotic Agents; J60AR2IKIC / Clozapine
  •  go-up   go-down


13. |||||||... 66%  Cerny J, Rosmarin AG: Why does my patient have leukocytosis? Hematol Oncol Clin North Am; 2012 Apr;26(2):303-19, viii
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Why does my patient have leukocytosis?
  • Leukocytosis is one of the most common laboratory abnormalities in medicine, and one of the most frequent reasons for hematologic consultation.
  • Effective evaluation of leukocytosis requires an attentive history, careful physical examination, meticulous review of the complete blood count and peripheral blood smear, judicious application of laboratory and radiologic testing, and thoughtful analysis.
  • Definitive diagnosis may require bone marrow aspiration and biopsy, imaging studies, and specialized molecular tests.
  • The differential diagnosis of leukocytosis includes physiologic responses to a broad range of infectious and inflammatory processes, as well as numerous primary hematologic disorders such as leukemias, lymphomas, and myeloproliferative neoplasms.
  • [MeSH-major] Leukocytosis / etiology
  • [MeSH-minor] Cell Differentiation. Humans. Leukocytes / cytology. Leukocytes / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2012 Elsevier Inc. All rights reserved.
  • (PMID = 22463829.001).
  • [ISSN] 1558-1977
  • [Journal-full-title] Hematology/oncology clinics of North America
  • [ISO-abbreviation] Hematol. Oncol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


14. ||||||.... 65%  Saaiq M, Niaz-Ud-Din, Jalil A, Zubair M, Shah SA: Diagnostic accuracy of leukocytosis in prediction of acute appendicitis. J Coll Physicians Surg Pak; 2014 Jan;24(1):67-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnostic accuracy of leukocytosis in prediction of acute appendicitis.
  • An analytical study was conducted to find out the diagnostic accuracy of leukocytosis in predicting acute appendicitis in patients undergoing emergency appendicectomy.
  • The operative findings were correlated with leukocyte counts using 2 x 2 table.
  • Out of 233 appendicectomies, with exclusion of the negative appendicectomies (17.59%, n = 41), there were 67.38% patients (n = 157) with elevated leukocyte count.
  • The overall sensitivity, specificity, positive predictive value and negative predictive value of elevated leukocyte counts for inflamed appendix were 91.81%, 43.55%, 81.77% and 65.85% respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24411549.001).
  • [ISSN] 1681-7168
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


15. ||||||.... 64%  Kondoh E, Shimizu M, Kakui K, Mikami Y, Tatsumi K, Konishi I: Deciduosis can cause remarkable leukocytosis and obscure abdominal pain. J Obstet Gynaecol Res; 2012 Dec;38(12):1376-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deciduosis can cause remarkable leukocytosis and obscure abdominal pain.
  • Remarkable leukocytosis with obscure abdominal pain during pregnancy is clinically challenging for obstetricians.
  • A 31-year-old pregnant woman developed persistently elevated white blood cell (approximately 30 000/µL) and C-reactive protein (3.0 mg/dL) with occasional moderate abdominal pain.
  • White blood cells rose 87200/µL, and C-reactive protein peaked at 44.9mg/dL after surgery.
  • Pathologically, biopsies showed deciduosis, and decidual cells on the omental surface showed immunohistochemical staining for granulocyte colony-stimulating factor (G-CSF).
  • G-CSF-producing deciduosis can induce leukocytosis as well as abdominal pain during pregnancy and postpartum.
  • [MeSH-major] Abdominal Pain / etiology. Leukocytosis / etiology. Pregnancy Complications / immunology

  • MedlinePlus Health Information. consumer health - Abdominal Pain.
  • MedlinePlus Health Information. consumer health - Health Problems in Pregnancy.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2012 The Authors. Journal of Obstetrics and Gynaecology Research © 2012 Japan Society of Obstetrics and Gynecology.
  • (PMID = 22612308.001).
  • [ISSN] 1447-0756
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


16. ||||||.... 63%  Aqil B, Green LK, Lai S: Primary splenic angiosarcoma associated with anemia, leukocytosis and thrombocytopenia. Ann Clin Lab Sci; 2014;44(2):217-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary splenic angiosarcoma associated with anemia, leukocytosis and thrombocytopenia.
  • Primary angiosarcoma of the spleen is a rare neoplasm arising from endothelial cells.
  • We report a case of 61-year-old Caucasian man who presented with shortness of breath, anemia, leukocytosis, and thrombocytopenia.
  • Image-guided Fine Needle Aspiration (FNA) revealed an atypical spindle cell lesion.
  • The patient appeared disease free after resection.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24795063.001).
  • [ISSN] 1550-8080
  • [Journal-full-title] Annals of clinical and laboratory science
  • [ISO-abbreviation] Ann. Clin. Lab. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. ||||||.... 63%  Ishii T, Sakamoto A, Matsuda S, Matsumoto Y, Harimaya K, Takahashi Y, Oda Y, Iwamoto Y: Leiomyosarcoma in the humerus with leukocytosis and elevation of serum G-CSF. Skeletal Radiol; 2012 Jun;41(6):719-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leiomyosarcoma in the humerus with leukocytosis and elevation of serum G-CSF.
  • Leukocytosis associated with secretion of granulocyte colony-stimulating factor (G-CSF) has been reported in various tumors, primarily poorly differentiated epithelial tumors, but is extremely rare in bone tumors.
  • Leukocytosis and elevated serum G-CSF were observed, but resolved following tumor resection.
  • A diagnosis of leiomyosarcoma of the bone with expression of G-CSF was confirmed immunohistochemically.
  • Histological diagnosis of leiomyosarcoma showed it to be differentiated, which is unusual for G-CSF-secreting tumors.
  • [MeSH-major] Bone Neoplasms / diagnosis. Granulocyte Colony-Stimulating Factor / blood. Humerus / pathology. Leiomyosarcoma / diagnosis. Leukocytosis / blood. Leukocytosis / diagnosis

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22167228.001).
  • [ISSN] 1432-2161
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 143011-72-7 / Granulocyte Colony-Stimulating Factor
  •  go-up   go-down


18. ||||||.... 60%  Njølstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J: Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol; 2013 Nov;131(2):410-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
  • OBJECTIVES: The objective of this study is to investigate preoperative hematological parameters for anemia, leukocytosis and thrombocytosis in relation to established prognostic factors and survival in endometrial cancer.
  • METHODS: 557 patients treated for endometrial carcinoma were prospectively included in a study focusing on the relationship between preoperative hemoglobin, leukocyte and platelet counts, and a panel of clinicopathological characteristics and outcome.
  • RESULTS: Preoperative anemia was present in 15.8%, leukocytosis in 11.2% and thrombocytosis in 12.1%.
  • Among patients with localized disease (FIGO stage I/II), 18.1% had anemia and/or thrombocytosis at diagnosis.
  • Patients with advanced disease (high FIGO stage and lymph-node metastasis) had significantly lower hemoglobin count, higher leukocyte count and higher platelet count (all p<0.008).
  • Patients with anemia, leukocytosis and thrombocytosis had significantly shorter 5-year disease-specific survival of 61.3%, 66.0% and 61.0% respectively, compared to 87.7%, 86.3% and 87.3% for patients with normal counts (all p<0.001).
  • CONCLUSION: Preoperative anemia, leukocytosis or thrombocytosis in women with endometrial carcinoma is associated with advanced disease and poor disease-specific survival.
  • [MeSH-major] Anemia / etiology. Endometrial Neoplasms / blood. Leukocytosis / etiology. Thrombocytosis / etiology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cohort Studies. Female. Hemoglobins / metabolism. Humans. Leukocyte Count. Middle Aged. Platelet Count. Preoperative Period. Prognosis. Proportional Hazards Models. Young Adult

  • Genetic Alliance. consumer health - Anemia.
  • MedlinePlus Health Information. consumer health - Anemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2013.
  • (PMID = 24004646.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Hemoglobins
  • [Keywords] NOTNLM ; Endometrial cancer / Leukocytosis / Preoperative anemia / Prognosis / Thrombocytosis
  •  go-up   go-down


19. ||||||.... 58%  Munoz J, Guo Y: Leukocytosis: the mysteries within. Am J Hematol; 2012 Feb;87(2):197
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukocytosis: the mysteries within.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Benzamides / therapeutic use. Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis. Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis. Leukocytosis / diagnosis. Piperazines / therapeutic use. Pyrimidines / therapeutic use
  • [MeSH-minor] Aged. Humans. Leukocyte Count. Male. Remission Induction

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Chronic Myeloid Leukemia.
  • HSDB. structure - IMATINIB MESYLATE.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21815181.001).
  • [ISSN] 1096-8652
  • [Journal-full-title] American journal of hematology
  • [ISO-abbreviation] Am. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; BKJ8M8G5HI / imatinib
  •  go-up   go-down


20. |||||..... 54%  Lee F, Yu MC: Association between peritoneal dialysate effluent leukocytosis and amlodipine besylate. Am J Kidney Dis; 2009 Mar;53(3):e1-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association between peritoneal dialysate effluent leukocytosis and amlodipine besylate.
  • Dialysate effluent leukocytosis is consistent with a greater degree of infection or inflammation in patients receiving peritoneal dialysis.
  • This study describes a girl aged 2 years 9 months with end-stage renal disease resulting from crescent glomerulonephritis and severe interstitial nephritis who developed leukocytosis with a predominance of lymphocytes in the dialysate effluent, and in whom the effluent cell count normalized 1 week after discontinuation of amlodipine besylate therapy.
  • Rechallenge confirmed that amlodipine was the offending agent causing effluent leukocytosis.
  • [MeSH-major] Amlodipine / adverse effects. Calcium Channel Blockers / adverse effects. Dialysis Solutions. Kidney Failure, Chronic / complications. Kidney Failure, Chronic / therapy. Leukocytosis / chemically induced. Peritoneal Dialysis, Continuous Ambulatory

  • MedlinePlus Health Information. consumer health - Kidney Failure.
  • HSDB. structure - AMLODIPINE BESYLATE.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19167800.001).
  • [ISSN] 1523-6838
  • [Journal-full-title] American journal of kidney diseases : the official journal of the National Kidney Foundation
  • [ISO-abbreviation] Am. J. Kidney Dis.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Calcium Channel Blockers; 0 / Dialysis Solutions; 1J444QC288 / Amlodipine
  •  go-up   go-down


21. |||||..... 54%  Weber KS, Defosse JM, Wappler F, Sakka SG: [Case report. Leukocytosis in the course of Clostridium difficile infection]. Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jun;48(6):386-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Case report. Leukocytosis in the course of Clostridium difficile infection].
  • [Transliterated title] Kasuistik. Leukozytose im Zuge einer Clostridium-difficile-Infektion.
  • Leukocytosis is a sign of severe CDI and is predictive for a complicated course.
  • In this case report, we describe 2 patients with CDI who developed leukocytosis within a leukemoid range.
  • In both cases high white blood cell counts returned totally to normal range under CDI therapy according to guidelines.
  • Leukemia-related therapy patterns were not needed.
  • [MeSH-major] Clostridium difficile. Enterocolitis, Pseudomembranous / complications. Leukocytosis / etiology

  • Genetic Alliance. consumer health - Clostridium Difficile.
  • MedlinePlus Health Information. consumer health - Clostridium Difficile Infections.
  • HSDB. structure - METRONIDAZOLE.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Georg Thieme Verlag Stuttgart · New York.
  • (PMID = 23828079.001).
  • [ISSN] 1439-1074
  • [Journal-full-title] Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
  • [ISO-abbreviation] Anasthesiol Intensivmed Notfallmed Schmerzther
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 140QMO216E / Metronidazole
  •  go-up   go-down


22. |||||..... 54%  [Iron metabolism regulatory mechanisms in initial leukocytosis in patients with acute leukemia]. Ter Arkh; 2011;83(10):22-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Iron metabolism regulatory mechanisms in initial leukocytosis in patients with acute leukemia].
  • AIM: To study levels of hepsidine (Hp), hypoxia-inducible factor-1alpha (HIF-1alpha), erythropoietin (EP) and ferritin in patients with acute leukemia (AL), effects of protein fractions of homogenate of blastic cells (BC) on regulatory proteins studied.
  • MATERIAL AND METHODS: Depending on leukocyte count in the onset of AL, 70 patients with first ever diagnosed AL were divided into two groups: group 1 - 17 patients with leukocyte count > 30 x 10(9)/l, group 2 - 53 patients with leukocyte count < 30 x 10(9)/l.
  • Serum and leukocyte parameters were studied before treatment, during the treatment with cytostatic drugs, in the course of myelotoxic agranulocytosis (MTA), after normalization of hemograms.
  • EP was detected with enzyme immunoassay, serum and leukocyte ferritin - with radioimmunoassay; HIF-1alpha, Hp - sandwich enzyme immunoassay using monospecific antisera and monoclonal antibodies against relevant antigens.
  • Leukocytes were isolated in ficol and verografin solutions density gradient.
  • Chromatographic division of the protein fractions in 3 patients with leukocytosis in AL onset and leukocytes of 3 donors was made by the method of preparative isoelectrofocusing of BC and leukocytes on LKB colon (Sweden).
  • RESULTS: Leukocytosis patients with initial AL have serum ferritin, Hp and HIF-1alpha levels about 2-5 times lower than patients without leukocytosis.
  • It is detected that protein fractions isolated from leukocytes of patients with leukocytosis in the disease onset raise HIF-1alpha content irrespective of HIF-1alpha presence in the fraction.
  • CONCLUSION: Great difficulties exist in ferritin and Hp levels between AL patients with leukocytosis in the onset of the disease and without of leukocytosis.
  • The study of leukocytes suggests that tumor cells of such patients contain compounds which can regulate production of HIF-1alpha, Hp and ferritin.
  • [MeSH-major] Iron / metabolism. Leukemia / blood. Leukocytosis / blood
  • [MeSH-minor] Acute Disease. Erythropoietin / blood. Erythropoietin / metabolism. Ferritins / blood. Ferritins / metabolism. Humans. Hypoxia-Inducible Factor 1, alpha Subunit / blood. Hypoxia-Inducible Factor 1, alpha Subunit / metabolism. Radioimmunoassay

  • MedlinePlus Health Information. consumer health - Iron.
  • MedlinePlus Health Information. consumer health - Leukemia.
  • HSDB. structure - IRON.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22185020.001).
  • [ISSN] 0040-3660
  • [Journal-full-title] Terapevticheskiĭ arkhiv
  • [ISO-abbreviation] Ter. Arkh.
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Hypoxia-Inducible Factor 1, alpha Subunit; 11096-26-7 / Erythropoietin; 9007-73-2 / Ferritins; E1UOL152H7 / Iron
  •  go-up   go-down


23. |||||..... 53%  Worley MJ Jr, Nitschmann CC, Shoni M, Rauh-Hain JA, Williams KA, Feltmate CM: Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma. Int J Gynecol Cancer; 2013 Feb;23(2):312-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma.
  • OBJECTIVE: To evaluate the impact of preoperative leukocytosis among patients with nonendometrioid endometrial carcinoma.
  • The patients were separated into 2 groups based on the presence or absence of preoperative leukocytosis (white blood cell count ≥ 10,000/μL).
  • RESULTS: A total of 222 patients were identified, and preoperative leukocytosis was observed in 33 patients (14.9%).
  • The leukocytosis group was associated with a larger mean size of the primary tumor (6.8 vs 4.6 cm, P = 0.016) and a greater percentage of patients with cervical stromal involvement (36.4% vs 20.1%, P = 0.039), adnexal involvement (42.4% vs. 22.8%, P = 0.017), and pelvic/para-aortic lymph node involvement (50% vs 27.4%, P = 0.025).
  • On multivariate analysis, preoperative leukocytosis was independently associated with an increased risk of recurrence (hazard ratio, 2.07; 95% confidence interval, 1.12-3.84) and an increased risk of death (hazard ratio, 3.33; 95% confidence interval, 2.01-5.53).
  • CONCLUSIONS: Among patients with nonendometrioid endometrial carcinoma, preoperative leukocytosis is independently associated with an increased risk of recurrence and death.
  • [MeSH-major] Endometrial Neoplasms / diagnosis. Endometrial Neoplasms / mortality. Leukocytosis / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23358179.001).
  • [ISSN] 1525-1438
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. |||||..... 53%  Paul DA, Zook K, Mackley A, Locke RG: Reduced mortality and increased BPD with histological chorioamnionitis and leukocytosis in very-low-birth-weight infants. J Perinatol; 2010 Jan;30(1):58-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reduced mortality and increased BPD with histological chorioamnionitis and leukocytosis in very-low-birth-weight infants.
  • OBJECTIVE: To investigate the association between leukocytosis, mortality and bronchopulmonary dysplasia (BPD) in very-low-birth-weight infants (VLBW) born to mothers with histological chorioamnionitis.
  • Total white blood cells (WBCs) after birth were measured.
  • Leukocytosis was defined as a total WBC count >30 000 per mm(3) in the first 2 days of life.
  • RESULT: After controlling for potential confounding variables, infants who developed a leukocytosis after birth had increased odds of BPD (4.6, 95% confidence interval (95% CI): 2.0 to 10.3), but decreased odds of death (0.3, 95% CI: 0.1 to 0.90).
  • CONCLUSION: In our population of VLBW infants born to mothers with histological chorioamnionitis, leukocytosis after birth is associated with a decrease in mortality but an increase in BPD.
  • [MeSH-major] Bronchopulmonary Dysplasia / blood. Chorioamnionitis / mortality. Infant, Very Low Birth Weight / blood. Leukocytosis / complications

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19710675.001).
  • [ISSN] 1476-5543
  • [Journal-full-title] Journal of perinatology : official journal of the California Perinatal Association
  • [ISO-abbreviation] J Perinatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. |||||..... 53%  Patel T, Wambi C, Berg WT, Bergman A, Shapiro EY, Badani KK: Characterization of perioperative leukocytosis in patients undergoing robot-assisted radical prostatectomy: effects of Gleason score and race. J Endourol; 2013 Dec;27(12):1463-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of perioperative leukocytosis in patients undergoing robot-assisted radical prostatectomy: effects of Gleason score and race.
  • INTRODUCTION: Our objective was to determine the impact of race and tumor grade on perioperative leukocytosis on patients undergoing robot-assisted radical prostatectomy (RARP).
  • White blood cell (WBC) counts were captured preoperatively, 1 hour postoperatively, and on postoperative day 1.
  • We assessed the differences in leukocyte responses according to the race and Gleason score using ANOVA testing.
  • RESULTS: Preoperative WBC was lowest in black men and comparable between white and Hispanic men.
  • At 1 hour, postoperative WBC remained lowest in Black men (p<0.001).
  • Post-RARP leukocytosis varied significantly depending on the race (p<0.001).
  • At 1 hour, patients with Gleason 8-10 tumors had decreased WBC compared to Gleason 6 patients (p<0.05) despite similar preoperative WBC and Charlson comorbidity index values.
  • [MeSH-major] Continental Population Groups. Leukocytosis / blood. Prostatectomy / methods. Prostatic Neoplasms / blood. Robotics
  • [MeSH-minor] Adult. Aged. Follow-Up Studies. Humans. Incidence. Leukocyte Count. Male. Middle Aged. Neoplasm Grading. Perioperative Period. Prognosis. Prostate-Specific Antigen / blood. Retrospective Studies. United States / epidemiology

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24074199.001).
  • [ISSN] 1557-900X
  • [Journal-full-title] Journal of endourology / Endourological Society
  • [ISO-abbreviation] J. Endourol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 3.4.21.77 / Prostate-Specific Antigen
  •  go-up   go-down


26. |||||..... 52%  Petterino C, Luzio E, Baracchini L, Ferrari A, Ratto A: Paraneoplastic leukocytosis in a dog with a renal carcinoma. Vet Clin Pathol; 2011 Mar;40(1):89-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paraneoplastic leukocytosis in a dog with a renal carcinoma.
  • Nonregenerative anemia, mild leukocytosis, marked hypoalbuminemia, and hematuria were observed.
  • Cytologic examination of fine-needle aspirates and imprints of the right kidney revealed a neoplastic cell population suggestive of renal carcinoma.
  • The histopathologic diagnosis was chromophobic cystic-papillary renal carcinoma.
  • The tumor cells expressed granulocytic/macrophage-colony-stimulating factor (GM-CSF), detected by immunohistochemical staining, and elaboration of GM-CSF by the tumor may have mediated the leukocytosis in this dog.
  • Following excision of the tumor, neutrophil and monocyte counts were only mildly increased.
  • The dog died 135 days after initial presentation, and a necropsy was not permitted.
  • Paraneoplastic neutrophilic leukocytosis is an uncommon finding and may be caused by elaboration of CSF by neoplastic cells.
  • [MeSH-major] Carcinoma, Renal Cell / veterinary. Dog Diseases / pathology. Kidney Neoplasms / veterinary. Leukocytosis / veterinary. Paraneoplastic Syndromes / veterinary

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] ©2011 American Society for Veterinary Clinical Pathology.
  • [CommentIn] Vet Clin Pathol. 2011 Jun;40(2):137; author reply 137 [21631565.001]
  • (PMID = 21291490.001).
  • [ISSN] 1939-165X
  • [Journal-full-title] Veterinary clinical pathology / American Society for Veterinary Clinical Pathology
  • [ISO-abbreviation] Vet Clin Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 83869-56-1 / Granulocyte-Macrophage Colony-Stimulating Factor
  •  go-up   go-down


27. |||||..... 52%  Claridge JA, Golob JF Jr, Fadlalla AM, Malangoni MA, Blatnik J, Yowler CJ: Fever and leukocytosis in critically ill trauma patients: it is not the blood. Am Surg; 2009 May;75(5):405-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fever and leukocytosis in critically ill trauma patients: it is not the blood.
  • The diagnosis of bacteremia in critically ill patients is classically based on fever and/or leukocytosis.
  • The objectives of this study were to determine 1) if our intensive care unit obtains blood cultures based on fever and/or leukocytosis over the initial 14 days of hospitalization after trauma; and 2) the efficacy of this diagnostic workup.
  • Data collected included demographics, injuries, and the first 14 days maximal daily temperature, leukocyte count, and results of blood and catheter tip cultures.
  • Fever was defined as a maximum daily temperature of 38.5 degrees C or greater and leukocytosis as a leukocyte count 12,000/mm3 or greater of blood.
  • Four hundred twenty-five blood culture episodes were obtained and 25 (6%) bacteremias were identified in 23 patients (5%).
  • A significant association was found between obtaining blood cultures in patients with fever (relative risk [RR], 7.7), leukocytosis (RR, 1.3), and fever + leukocytosis (RR, 3.2).
  • However, no significant association was found between these clinical signs and the diagnosis of bacteremia.
  • Our intensive care unit follows the common "fever workup" practice and obtains blood cultures based on the presence of fever and leukocytosis.
  • However, fever and leukocytosis were not associated with bacteremia, suggesting inefficiency and that other factors are more important after trauma.
  • [MeSH-major] Bacteremia / microbiology. Critical Illness. Fever / etiology. Leukocytosis / etiology. Wounds and Injuries / complications

  • MedlinePlus Health Information. consumer health - Fever.
  • MedlinePlus Health Information. consumer health - Wounds and Injuries.
  • COS Scholar Universe. author profiles.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19445292.001).
  • [ISSN] 0003-1348
  • [Journal-full-title] The American surgeon
  • [ISO-abbreviation] Am Surg
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / 1KL2RR024990; United States / NCRR NIH HHS / RR / KL2 RR024990
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


28. |||||..... 52%  Cooper ES, Berry MP, McMurray RG, Hosick PA, Hackney AC: Core temperature influences on the relationship between exercise-induced leukocytosis and cortisol or TNF-alpha. Aviat Space Environ Med; 2010 May;81(5):460-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Core temperature influences on the relationship between exercise-induced leukocytosis and cortisol or TNF-alpha.
  • INTRODUCTION: The extent to which exercise in the heat modifies leukocytosis and the relationship between the leukocytosis and tumor necrosis factor-alpha (TNF-alpha) or cortisol is not well understood.
  • Thus, this study attempted to determine the combined effect of exercise and differing elevations in core temperature on exercise-induced leukocytosis and to examine associations between any leukocytosis and cortisol orTNF-alpha.
  • Leukocytes, TNF-alpha, and cortisol were determined at baseline, immediately post-, and 2 h post-exercise.
  • RESULTS: Both trials resulted in significant 13-33% increases in total leukocytes, mostly driven by a 24-30% increase in neutrophils.
  • A significant relationship was found between the change in core temperature (T(re)) during exercise and the increase in total leukocytes (r = 0.561).
  • Yet the exercise-induced change in cortisol was not significantly correlated to any changes in leukocytes.
  • There was a trend for the relationships between the exercise-induced change in TNF-alpha and the changes in total leukocytes (r = 0.491) and neutrophils (r = 0.479).
  • DISCUSSION: These results suggest that although neither cortisol nor TNF-alpha are strong predictors of the leukocyte response during exercise or recovery, each factor may be one of many potential modifiers of the total leukocyte response.
  • [MeSH-major] Body Temperature / physiology. Exercise / physiology. Hot Temperature. Hydrocortisone / blood. Leukocytosis. Tumor Necrosis Factor-alpha / blood

  • MedlinePlus Health Information. consumer health - Exercise and Physical Fitness.
  • HSDB. structure - HYDROCORTISONE.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20464812.001).
  • [ISSN] 0095-6562
  • [Journal-full-title] Aviation, space, and environmental medicine
  • [ISO-abbreviation] Aviat Space Environ Med
  • [Language] eng
  • [Publication-type] Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Tumor Necrosis Factor-alpha; WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


29. |||||..... 52%  Qiu MZ, Xu RH, Ruan DY, Li ZH, Luo HY, Teng KY, Wang ZQ, Li YH, Jiang WQ: Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol; 2010 Dec;31(6):633-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China.
  • We identified all patients in Cancer Center of Sun Yat-sen University who were diagnosed as solid tumors (breast carcinoma, hepatocellular carcinoma, nasopharyngeal carcinoma, esophageal carcinoma, gastric cancer, cervical carcinoma, endometrial cancer, renal cell carcinoma, and non-small cell lung cancer) between January 2000 and August 2009.
  • All subjects were investigated regarding levels of white blood cells, platelets, and hemoglobin concentration.
  • The percentages of leukocytosis, anemia, and thrombocytosis in patients with solid tumors ranged from 4.0% to 25.6%, 3.3% to 29.2%, and 2.1% to 9.7%, respectively.
  • Leukocytosis was an independent prognostic factor in patients with cervical cancer (P = 0.007).
  • A pretreatment anemia or leukocytosis can serve as a useful marker to predict outcome of patients in some of the solid tumors.
  • [MeSH-major] Anemia / epidemiology. Breast Neoplasms / complications. Esophageal Neoplasms / complications. Leukocytosis / epidemiology. Liver Neoplasms / complications. Stomach Neoplasms / complications. Thrombocytosis / epidemiology


30. |||||..... 51%  Tompkins C, Cheng A, Brinker JA, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA: Significance of leukocytosis after cardiac device implantation. Am J Cardiol; 2013 Jun 1;111(11):1608-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Significance of leukocytosis after cardiac device implantation.
  • Whether early postprocedural leukocytosis, a recognized marker of infection, is an indicator of impending infection is unclear and was the focus of this study.
  • The association between change in white blood cell (WBC) count and development of infection after device implantation was assessed.
  • Pre- and postprocedural WBC counts were obtained within 48 hours of the procedure.
  • Significant leukocytosis was defined as a ≥50% increase in WBC count; 1,245 device implantations met inclusion criteria.
  • A modest 17.6 ± 30.2% increase in WBC count was observed for the entire cohort.
  • Cases resulting in infection demonstrated minimal change in WBC count (mean +5.5 ± 26.5%).
  • No infections occurred in patients with ≥50% increases in WBC count or postprocedural WBC counts >15,000/μl.
  • Subjects with significant leukocytosis were younger (mean age 61.9 ± 16.5 vs 65.6 ± 15.1 years, p <0.01), had longer procedure times (mean 198 ± 97 vs 170 ± 77 minutes, p <0.001), and received biventricular implantable cardioverter-defibrillators (25% vs 13.9%, p <0.001).
  • In conclusion, after device implantation, a ≥50% increase in WBC count occurred in about 10% to 15% of patients.
  • Age, race, type of device, and procedure time influenced the development of significant leukocytosis.
  • Elevation in WBC count after cardiac device implantation was not associated with an increased risk for early infection.
  • [MeSH-major] Arrhythmias, Cardiac / therapy. Bacteremia / complications. Defibrillators, Implantable / adverse effects. Leukocytosis / etiology. Pacemaker, Artificial / adverse effects. Prosthesis-Related Infections / complications
  • [MeSH-minor] Aged. Female. Follow-Up Studies. Humans. Incidence. Leukocyte Count. Male. Middle Aged. Retrospective Studies. Severity of Illness Index. United States / epidemiology

  • MedlinePlus Health Information. consumer health - Arrhythmia.
  • MedlinePlus Health Information. consumer health - Pacemakers and Implantable Defibrillators.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2013 Elsevier Inc. All rights reserved.
  • (PMID = 23523060.001).
  • [ISSN] 1879-1913
  • [Journal-full-title] The American journal of cardiology
  • [ISO-abbreviation] Am. J. Cardiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. |||||..... 50%  Chou YS, Gau JP, Yu YB, Pai JT, Hsiao LT, Liu JH, Hong YC, Liu CY, Yang CF, Chen PM, Chiou TJ, Tzeng CH: Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhage. Eur J Haematol; 2013 Mar;90(3):228-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhage.
  • BACKGROUND: Long-term outcomes are favorable for patients with polycythemia vera (PV) and for patients with essential thrombocythemia (ET).
  • METHODS: We retrospectively recruited 247 patients who had received a diagnosis of PV (n = 101) or ET (n = 146) during the period 2001-2010.
  • RESULTS: After a median follow-up period of 36.2 months, the cumulative incidence of hemorrhage was 39.6% in patients with PV (6.2% per person-year) and 29.7% in patients with ET (5.9% person-years).
  • Episodes of major bleeding occurred in 9.9% of patients with PV and in 14.4% of patients with ET.
  • Overall survival was significantly shorter among patients with hemorrhage than among those without said complication (P < 0.001 for overall patients; P = 0.002 for patients with PV; P = 0.026 for patients with ET).
  • In the univariate analysis, age ≥ 60 yr (OR: 4.77, P = 0.046) and WBC ≥ 16 × 10(9) /L (OR: 4.15, P = 0.010) were predictors of hemorrhage in patients with PV, and age ≥ 60 yr (OR: 3.25, P = 0.040), WBC ≥ 16 × 10(9) /L (OR: 2.89, P = 0.024), albumin <4.0 g/dL (OR: 4.10, P = 0.002), and splenomegaly (OR: 5.19, P = 0.002) were predictors of hemorrhage in patients with ET.
  • Multivariate analysis showed that WBC ≥ 16 × 10(9) /L was the only significant risk factor for hemorrhage in patients with PV (OR: 3.51, P = 0.026) and that splenomegaly was the only risk factor for hemorrhage in patients with ET (OR: 3.00, P = 0.048).
  • CONCLUSION: Leukocytosis in PV and splenomegaly in ET are independent risk factors for hemorrhage.
  • [MeSH-major] Hemorrhage / complications. Leukocytosis / complications. Polycythemia Vera / complications. Splenomegaly / complications. Thrombocythemia, Essential / complications
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Incidence. Leukocyte Count. Leukocytes / pathology. Male. Middle Aged. Retrospective Studies. Risk Factors. Survival Rate


32. |||||..... 50%  Canzoneri BJ, Lewis DF, Groome L, Wang Y: Increased neutrophil numbers account for leukocytosis in women with preeclampsia. Am J Perinatol; 2009 Nov;26(10):729-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased neutrophil numbers account for leukocytosis in women with preeclampsia.
  • We evaluated the leukocyte differentials in women with normal pregnancies and in pregnancies complicated by preeclampsia (PE).
  • Leukocyte total and neutrophil, lymphocyte, monocyte, eosinophil, basophil, hemoglobin, and platelet counts were analyzed by analysis of variance and pairwise comparison.
  • The total leukocyte count was significantly increased in women with severe PE compared with women with mild PE and normal pregnant controls: 10.66 +/- 3.70 ( P < 0.0001) versus 9.47 +/- 2.59 and 8.55 +/- 1.93 (1 x 10 (3)/microL), respectively.
  • The increased total leukocyte count was mainly due to the increase in neutrophil numbers: 8.05 +/- 4.01 (severe; P < 0.0001) versus 6.69 +/- 2.23 (mild) and 5.90 +/- 1.79 (controls), respectively.
  • The total neutrophil count was further increased 48 hours after delivery in the group with severe PE.
  • Increased neutrophil numbers account for the leukocytosis in women with PE.
  • [MeSH-major] Leukocytosis / blood. Leukocytosis / epidemiology. Neutrophils / metabolism. Pre-Eclampsia / blood. Pre-Eclampsia / epidemiology
  • [MeSH-minor] Adult. Causality. Comorbidity. Erythrocyte Count. Female. Humans. Louisiana. Lymphocyte Count. Platelet Count. Pregnancy. Reference Values. Retrospective Studies. Risk Factors. Severity of Illness Index

  • Genetic Alliance. consumer health - Preeclampsia.
  • COS Scholar Universe. author profiles.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) Thieme Medical Publishers.
  • [Cites] South Med J. 2000 Aug;93(8):768-71 [10963506.001]
  • [Cites] JAMA. 1979 Dec 14;242(24):2696-8 [501868.001]
  • [Cites] Br J Obstet Gynaecol. 1989 Aug;96(8):978-82 [2775697.001]
  • [Cites] Obstet Gynecol. 1991 Jul;78(1):28-32 [2047063.001]
  • [Cites] Acta Paediatr. 1992 Oct;81(10):760-3 [1421878.001]
  • [Cites] Obstet Gynecol. 1993 Apr;81(4):536-40 [8384706.001]
  • [Cites] Am J Obstet Gynecol. 1999 Aug;181(2):408-14 [10454692.001]
  • [Cites] Br J Obstet Gynaecol. 1997 Jul;104(7):851-3 [9236656.001]
  • [Cites] Gynecol Obstet Invest. 1998;45(4):229-31 [9623786.001]
  • [Cites] Am J Obstet Gynecol. 1998 Nov;179(5):1359-75 [9822529.001]
  • [Cites] Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):499-506 [9988826.001]
  • [Cites] Br J Obstet Gynaecol. 1999 Jun;106(6):576-81 [10426616.001]
  • [Cites] Clin Sci (Lond). 1997 Jan;92(1):37-44 [9038589.001]
  • (PMID = 19452432.001).
  • [ISSN] 1098-8785
  • [Journal-full-title] American journal of perinatology
  • [ISO-abbreviation] Am J Perinatol
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD036822-08; United States / NHLBI NIH HHS / HL / R01 HL065997-08
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS266056; NLM/ PMC3062252
  •  go-up   go-down


33. |||||..... 48%  Asadollahi K, Beeching NJ, Gill GV: Leukocytosis as a predictor for non-infective mortality and morbidity. QJM; 2010 May;103(5):285-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukocytosis as a predictor for non-infective mortality and morbidity.
  • Leukocytosis (raised concentration of white cells in the blood) is commonly associated with infection or inflammation, but can occur in a wide variety of other conditions.
  • Leukocytosis has also been linked with increased mortality and morbidity in a number of studies.
  • We have systematically reviewed the relevant literature, which clearly demonstrates an association between leukocytosis and mortality-particularly due to cardiovascular or cerebrovascular causes.
  • The mechanisms of this effect are uncertain but, when combined with other markers predictive of death, leukocytosis may contribute to modelling systems to predict in-patient mortality risk.
  • [MeSH-major] Cardiovascular Diseases / mortality. Leukocytosis / mortality

  • COS Scholar Universe. author profiles.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20056764.001).
  • [ISSN] 1460-2393
  • [Journal-full-title] QJM : monthly journal of the Association of Physicians
  • [ISO-abbreviation] QJM
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Number-of-references] 46
  •  go-up   go-down


34. |||||..... 48%  Mabuchi S, Matsumoto Y, Isohashi F, Yoshioka Y, Ohashi H, Morii E, Hamasaki T, Aozasa K, Mutch DG, Kimura T: Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol Oncol; 2011 Jul;122(1):25-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer.
  • OBJECTIVES: The aim of this study was to investigate the prognostic value of pretreatment leukocytosis in patients with cervical cancer in relation to well-established conventional risk factors.
  • Subsequently, the prognostic significance of pretreatment WBC count was prospectively investigated in 156 patients newly diagnosed cervical cancer from 2007 April to 2010 March.
  • RESULTS: In a retrospective analysis, patients with leukocytosis (WBC ≥ 10,000/μl) showed significantly higher treatment failure rate (P < 0.0001) and shorter OS (P < 0.0001) than the patients without leukocytosis.
  • Tumors from patients with leukocytosis showed significantly stronger immunoreactivity for G-CSF than those obtained from patients without leukocytosis.
  • Multivariate analyses revealed that clinical stage, tumor diameter, histology, and elevated WBC count (≥ 10,000/μl) were significant prognostic factors in terms of overall survival.
  • In a prospective investigation, patients with leukocytosis showed significantly higher treatment failure rate (P < 0.0001), shorter PFS (P < 0.0001), and higher serum G-CSF concentrations (p = 0.001) than the patients without leukocytosis.
  • Multivariate analyses revealed that clinical stage, tumor diameter, and elevated WBC count were significant prognostic factors in terms of PFS.
  • CONCLUSION: Pretreatment leukocytosis is an independent prognostic factor in patients with cervical cancer.
  • Our finding can be used to identify patients with poor prognosis and to design future tailored clinical trials.
  • [MeSH-major] Leukocytosis / pathology. Uterine Cervical Neoplasms / blood
  • [MeSH-minor] Adult. Aged. Female. Granulocyte Colony-Stimulating Factor / biosynthesis. Granulocyte Colony-Stimulating Factor / blood. Humans. Leukocyte Count. Middle Aged. Neoplasm Staging. Neutrophils / pathology. Prognosis. Proportional Hazards Models. Retrospective Studies. Risk Factors


35. |||||..... 48%  Mehtap O, Ateşoğlu EB, Tarkun P, Gönüllü E, Keski H, Topçu Y, Uzülmez N, Sünnetçi D, Hacıhanefioğlu A: The association between gene polymorphisms and leukocytosis with thrombotic complications in patients with essential thrombocythemia and polycythemia vera. Turk J Haematol; 2012 Jun;29(2):162-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The association between gene polymorphisms and leukocytosis with thrombotic complications in patients with essential thrombocythemia and polycythemia vera.
  • Objective: Vascular events are a common complication in patients with polycythemia vera (PV) and essential thrombocythemia (ET).
  • This study aimed to analyze the association between PAI-1 4G/5G and ACE I/D gene polymorphisms, and leukocytosis with thrombosis in patients with PV and ET.
  • Material and Methods: In total, 64 patients with ET and PV were evaluated.
  • Vascular events were significantly more common in the patients with leukocytosis (leukocyte count >10 × 109 L-1) than in those without leukocytosis (leukocyte count ≤10 × 109 L-1) (P = 0.00).
  • Conclusion: PAI-1 and ACE gene polymorphisms were not considered new risk factors for thrombosis in PV and ET patients.
  • On the other hand, leukocytosis at diagnosis was associated with the occurrence of vascular events in the patients with ET and PV.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24744648.001).
  • [ISSN] 1300-7777
  • [Journal-full-title] Turkish journal of haematology : official journal of Turkish Society of Haematology
  • [ISO-abbreviation] Turk J Haematol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Turkey
  • [Other-IDs] NLM/ PMC3986955
  • [Keywords] NOTNLM ; ACE I/D / Essential thrombocythemia / Leukocytosis / PAI-1 4G/5G / Polycythemia vera / Thrombosis
  •  go-up   go-down


36. |||||..... 48%  Díaz-Rosales Jde D, Enríquez-Domínguez L, Castillo-Moreno JR, Herrera-Ramírez F: [Preoperative leukocytosis as a predictor of intrabdominal injury in penetrating abdominal trauma]. Cir Cir; 2012 Nov-Dec;80(6):516-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Preoperative leukocytosis as a predictor of intrabdominal injury in penetrating abdominal trauma].
  • [Transliterated title] Leucocitosis prequirúrgica como factor predictivo de lesión a órgano intrabdominal en trauma penetrante abdominal.
  • Is possible use some grade of leukocytosis suspect in-trabdominal lesion?
  • Dependent variables were; age, gender, type of injury, number of lesions, peripheral lesions, time between injury and, from a laboaratory blood sample, leukocytosis mean, percentage of neutrophils, leukocytosis ≥ 12,500 /mm(3), and hemoperitoneum.
  • Leukocytosis global was 13.2 mil/mm(3) and neutrophil range of 70.3%.
  • 26% of patients did not have leukocytosis at arrival and evaluation, however they were laparotomized because of present peritoneal irritation.
  • Leukocytosis ≥ 12.5 mil/mm(3) was statistically significant in patients with intrabdominal lesions (74.2% vs 27.7%, p < 0.001).
  • CONCLUSIONS: leukocytosis ≥ 12.5 mil/mm(3) could be an early serum marker abdominal penetrating trauma.
  • [MeSH-major] Abdominal Injuries / blood. Leukocytosis / etiology. Peritoneum / injuries. Preoperative Care. Viscera / injuries. Wounds, Penetrating / blood
  • [MeSH-minor] Adolescent. Adult. Female. Hemoperitoneum / epidemiology. Hemoperitoneum / etiology. Humans. Laparotomy / methods. Laparotomy / utilization. Length of Stay / statistics & numerical data. Leukocyte Count. Male. Mexico / epidemiology. Middle Aged. Predictive Value of Tests. Retrospective Studies. Trauma Centers / statistics & numerical data. Triage. Wounds, Gunshot / blood. Wounds, Gunshot / diagnosis. Wounds, Gunshot / epidemiology. Wounds, Gunshot / surgery. Wounds, Stab / blood. Wounds, Stab / diagnosis. Wounds, Stab / epidemiology. Wounds, Stab / surgery. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23336145.001).
  • [ISSN] 0009-7411
  • [Journal-full-title] Cirugia y cirujanos
  • [ISO-abbreviation] Cir Cir
  • [Language] spa
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


37. |||||..... 47%  Hurtado-Cordovi J, Pathak P, Avezbakiyev B, Frieri M: Inflammatory malignant fibrous histiocytoma associated with leukemoid reaction or leukocytosis: a comprehensive review. ISRN Oncol; 2012;2012:946019
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inflammatory malignant fibrous histiocytoma associated with leukemoid reaction or leukocytosis: a comprehensive review.
  • Inflammatory malignant fibrous histiocytoma (IMFH) associated with leukemoid reaction (LR)/leukocytosis is a rare entity.
  • In this paper, we search PubMed for all known cases of IMFH associated with LR/leukocytosis in an attempt to draw conclusions about this variant's response to treatments and its pathophysiology.
  • Medline electronic database was searched using key words such as malignant fibrous histiocytoma, leukemoid reaction, and leukocytosis.
  • Of the 12 patients that expired, death occurred approximately 92 days after the onset of LR or leukocytosis, ranging from 3 to 334 days.
  • We conclude that IMFH associated with LR/leukocytosis does not completely respond to chemoradiation.
  • Overproduction of growth factors and cytokines by IMFH cells and their interactions with the inflammatory infiltrate seem to promote immunological effector cell's dysfunction and substantiate the development and growth of this neoplasm.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Immunol Rev. 2008 Apr;222:162-79 [18364001.001]
  • [Cites] Cancer Cell. 2008 Mar;13(3):193-205 [18328424.001]
  • [Cites] J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S272-83 [20061007.001]
  • [Cites] Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1711-6 [21220338.001]
  • [Cites] PLoS One. 2011;6(11):e27690 [22110722.001]
  • [Cites] Case Rep Med. 2012;2012:798629 [22844297.001]
  • [Cites] Case Rep Oncol. 2011;4(2):343-9 [21769293.001]
  • [Cites] Cancer. 1979 May;43(5):1800-4 [221097.001]
  • [Cites] Am J Surg Pathol. 1992 Mar;16(3):213-28 [1317996.001]
  • [Cites] Oncology. 1986;43(4):230-3 [2425319.001]
  • [Cites] Histopathology. 1989 Mar;14(3):319-21 [2540087.001]
  • [Cites] Pathol Res Pract. 1989 May;184(5):498-506 [2546130.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1980;388(2):237-43 [6259806.001]
  • [Cites] Ann Intern Med. 1982 Dec;97(6):858-63 [6293357.001]
  • [Cites] Laryngoscope. 1983 Oct;93(10):1351-8 [6312224.001]
  • [Cites] Blood. 1993 Feb 1;81(3):656-60 [7678995.001]
  • [Cites] Gastroenterol Jpn. 1993 Aug;28(4):554-63 [7690726.001]
  • [Cites] Blood. 1993 Oct 1;82(7):2038-44 [7691245.001]
  • [Cites] Cancer. 1994 Oct 15;74(8):2251-60 [7922976.001]
  • [Cites] Jpn J Clin Oncol. 1994 Jun;24(3):154-9 [8007425.001]
  • [Cites] Crit Rev Oncog. 1993;4(5):473-92 [8241321.001]
  • [Cites] J Cutan Pathol. 1997 Aug;24(7):393-7 [9274955.001]
  • [Cites] Pathol Int. 1997 Sep;47(9):642-6 [9311018.001]
  • [Cites] Eur J Cancer. 1998 Dec;34(13):2094-100 [10070317.001]
  • [Cites] Scand J Urol Nephrol. 2000 Jun;34(3):208-10 [10961478.001]
  • [Cites] Surg Today. 2002;32(1):81-5 [11871825.001]
  • [Cites] Pathol Int. 2002 Sep;52(9):595-606 [12406189.001]
  • [Cites] Anticancer Res. 2003 May-Jun;23(3B):2329-33 [12894511.001]
  • [Cites] Anticancer Res. 2003 Sep-Oct;23(5b):4305-8 [14666642.001]
  • [Cites] Clin Cancer Res. 2004 Sep 1;10(17):5804-7 [15355909.001]
  • [Cites] Semin Cancer Biol. 2006 Feb;16(1):53-65 [16168663.001]
  • [Cites] Am J Hematol. 2005 Nov;80(3):243-5 [16247754.001]
  • [Cites] Int J Urol. 2006 Jul;13(7):1000-2 [16882073.001]
  • [Cites] Anticancer Res. 2007 Jan-Feb;27(1A):423-9 [17352263.001]
  • [Cites] Acta Histochem Cytochem. 2006 Mar 2;39(1):17-21 [17460768.001]
  • [Cites] Oncologist. 2007 Aug;12(8):999-1006 [17766660.001]
  • [Cites] Expert Rev Anticancer Ther. 2009 Aug;9(8):1135-44 [19671033.001]
  • [Cites] Ultraschall Med. 2011 Feb;32(1):1-4 [20408125.001]
  • [Cites] Ann Thorac Surg. 2010 Jun;89(6):2003-5 [20494067.001]
  • [Cites] J Immunol. 2010 Aug 15;185(4):2273-84 [20644162.001]
  • [Cites] Int J Cancer. 2011 Oct 15;129(8):1963-9 [21154746.001]
  • [Cites] Int Immunopharmacol. 2011 Jul;11(7):816-26 [21376153.001]
  • [Cites] Curr Cancer Drug Targets. 2011 Jul;11(6):734-51 [21599634.001]
  • [Cites] Cancer. 1976 Mar;37(3):1584-1606 [177172.001]
  • [Cites] Cancer. 1978 Apr;41(4):1467-71 [205339.001]
  • [Cites] Cancer. 1978 Jun;41(6):2250-66 [207408.001]
  • [Cites] Gynecol Oncol. 1999 Dec;75(3):484-9 [10600313.001]
  • [Cites] Intern Med. 2001 Jun;40(6):536-40 [11446682.001]
  • [Cites] Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):721s-726s [17255300.001]
  • [Cites] J Clin Invest. 2007 Nov;117(11):3248-57 [17948129.001]
  • [Cites] Semin Musculoskelet Radiol. 2007 Sep;11(3):201-14 [18260031.001]
  • [Cites] Breast Cancer Res Treat. 2010 Aug;123(1):39-49 [19898981.001]
  • (PMID = 23097722.001).
  • [ISSN] 2090-567X
  • [Journal-full-title] ISRN oncology
  • [ISO-abbreviation] ISRN Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  • [Other-IDs] NLM/ PMC3477745
  •  go-up   go-down


38. |||||..... 47%  Deirmengian GK, Zmistowski B, Jacovides C, O'Neil J, Parvizi J: Leukocytosis is common after total hip and knee arthroplasty. Clin Orthop Relat Res; 2011 Nov;469(11):3031-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukocytosis is common after total hip and knee arthroplasty.
  • Although leukocytosis may be a sign of a developing infection in the early postoperative period, it may also be part of a normal surgical response.
  • QUESTIONS AND PURPOSES: We determined (1) the natural history of white blood cell values after primary THA and TKA, (2) factors associated with early postoperative leukocytosis, and (3) the predictive value of white blood cell count for early postoperative periprosthetic joint infection.
  • We determined the incidence of leukocytosis and characterized the natural history of postoperative white blood cell counts.
  • We then investigated potential indicators of postoperative leukocytosis, including development of early periprosthetic infection.
  • RESULTS: The average postoperative white blood cell count increased to approximately 3 × 10(6) cells/μL over the first 2 postoperative days and then declined to a level slightly higher than the preoperative level by Postoperative Day 4.
  • The incidence of postoperative leukocytosis for all patients was 38%.
  • Factors associated with postoperative leukocytosis included TKA, bilateral procedures, older age, and higher modified Charlson Comorbidity Index.
  • The sensitivity and specificity of white blood cell count for diagnosing early periprosthetic infection were 79% and 46%, respectively.
  • CONCLUSIONS: Postoperative leukocytosis is common after THA and TKA and represents a normal physiologic response to surgery.
  • In the absence of abnormal clinical signs and symptoms, postoperative leukocytosis may not warrant further workup for infection.
  • [MeSH-major] Arthroplasty, Replacement, Hip / adverse effects. Arthroplasty, Replacement, Knee / adverse effects. Leukocytosis / diagnosis. Prosthesis-Related Infections / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Comorbidity. Databases, Factual. Female. Humans. Leukocyte Count. Male. Middle Aged. Pennsylvania / epidemiology. Postoperative Complications. Predictive Value of Tests. Young Adult

  • MedlinePlus Health Information. consumer health - Hip Replacement.
  • MedlinePlus Health Information. consumer health - Knee Replacement.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Am. 1999 Oct;81(10):1434-45 [10535593.001]
  • [Cites] Clin Orthop Relat Res. 1999 Oct;(367):181-9 [10546613.001]
  • [Cites] J Clin Epidemiol. 1992 Jun;45(6):613-9 [1607900.001]
  • [Cites] J Arthroplasty. 2010 Sep;25(6 Suppl):43-8 [20452174.001]
  • [Cites] J Bone Joint Surg Am. 1999 May;81(5):672-83 [10360695.001]
  • [Cites] Br J Biomed Sci. 2006;63(4):166-70 [17201205.001]
  • [Cites] Clin Orthop Relat Res. 2010 Mar;468(3):762-8 [19768513.001]
  • [Cites] J Bone Joint Surg Am. 1996 Apr;78(4):512-23 [8609130.001]
  • (PMID = 21461866.001).
  • [ISSN] 1528-1132
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3183208
  •  go-up   go-down


39. |||||..... 47%  Gangat N, Wolanskyj AP, Schwager SM, Hanson CA, Tefferi A: Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera. Cancer; 2009 Dec 15;115(24):5740-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera.
  • BACKGROUND: Advanced age and a history of thrombosis were well-established risk factors for thrombosis in essential thrombocythemia (ET) and polycythemia vera (PV); cytoreductive therapy was indicated in their presence.
  • Recent studies have suggested leukocytosis as an additional risk factor; however, such an association would be treatment-relevant in the context of low-risk disease.
  • METHODS: In this retrospective study, a Cox proportional hazards model was used to determine the impact of various clinical and laboratory variables, including leukocytosis, on thrombosis-free survival (TFS).
  • Arterial-specific or venous-specific TFS curves for different leukocyte count-defined risk groups were constructed by the Kaplan-Meier method and compared using the log-rank test.
  • RESULTS: A total of 407 low-risk patients (254 with ET and 153 with PV) were considered.
  • After a respective median follow-up of 104 months and 130 months, respectively, 47 (19%) patients with ET and 41 (27%) with PV experienced a total of 55 (41 arterial and 14 venous) and 46 (22 arterial and 24 venous) thrombotic events, respectively.
  • Leukocytosis at the time of diagnosis, defined by a cutoff level of either 15 or 9.4x10(9)/L, did not appear to be predictive of either arterial or venous thrombosis during follow-up; similar results were obtained when analysis was restricted to patients with platelet counts of <1000x10(9)/L.
  • Instead, advanced age was found to be significantly associated with arterial thrombosis in patients with PV and higher hemoglobin level with venous thrombosis in patients with ET.
  • CONCLUSIONS: In the current retrospective study, leukocytosis at diagnosis did not appear to influence the risk of thrombosis in either ET or PV.
  • However, a prospective study is required before leukocytosis is taken into account during treatment decisions in these disorders.
  • [MeSH-major] Leukocytosis / complications. Polycythemia Vera / complications. Thrombocythemia, Essential / complications. Thrombosis / complications


40. |||||..... 47%  Banerjee R, Roxin G, Eliasziw M, Joseph K, Maclean A, Buie WD, Doll C: The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy. Dis Colon Rectum; 2013 Sep;56(9):1036-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The prognostic significance of pretreatment leukocytosis in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy.
  • BACKGROUND: There are emerging data showing the prognostic significance of pretreatment leukocytosis in patients with cervical cancer; it is generally associated with adverse outcome.
  • However, the prognostic impact of leukocytosis in patients with anal cancer has not been previously reported.
  • OBJECTIVE: The purpose of this study was to assess the relationship between pretreatment leukocytosis and clinical outcomes in patients with anal cancer treated with radical chemoradiotherapy or radiotherapy.
  • MAIN OUTCOME MEASURES: The primary outcomes were disease-free and overall survival.
  • Pretreatment leukocytosis (white blood cell count >10 × 10/L) was identified in 15.9% (20/126) of patients.
  • After adjusting for sex, tumor size, and stage in a multivariate analysis, leukocytosis remained significantly associated with worse disease-free survival (HR, 2.2; 95% CI, 1.1-4.8; p = 0.045) and worse overall survival (HR, 2.9; 95% CI, 1.1-7.9; p = 0.036).
  • Patients with both leukocytosis and anemia (pretreatment hemoglobin <125 g/L) had the worst prognosis: 2-year disease-free survival 42.1% versus 72.9% for patients without these factors (HR, 2.7; 95% CI, 1.1-6.8; p = 0.033); 2-year overall survival 60.9% versus 89.8% (HR, 4.5; 95% CI, 1.5-13.2; p = 0.006).
  • LIMITATIONS: The study was limited by its retrospective nature and lack of patients with multiple hematologic abnormalities (ie, both anemia and leukocytosis).
  • CONCLUSIONS: Pretreatment leukocytosis in patients with anal cancer is associated with significantly worse disease-free and overall survival, which appears to be exacerbated with the presence of pretreatment anemia.
  • [MeSH-major] Anus Neoplasms / therapy. Carcinoma, Adenosquamous / therapy. Carcinoma, Squamous Cell / therapy. Chemoradiotherapy. Leukocytosis / diagnosis

  • Genetic Alliance. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23929012.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


41. |||||..... 46%  Sand KL, Flatebo T, Andersen MB, Maghazachi AA: Effects of exercise on leukocytosis and blood hemostasis in 800 healthy young females and males. World J Exp Med; 2013 Feb 20;3(1):11-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of exercise on leukocytosis and blood hemostasis in 800 healthy young females and males.
  • Blood samples were collected before and after exercise.
  • RESULTS: We observed that in the first group a significant increase of the total white blood cells, segmented neutrophils, band neutrophils, eosinophils and to a lesser extent lymphocytes but not monocytes in the blood circulation.
  • However, all cell types were increased in the circulation after 5 min intense exercise.
  • No differences in the pattern of cell increase were observed among the genders.
  • Activated partial thromboplastin time (APTT) and D-dimer were also measured in the blood of individuals who cycled intensely for 5 min to determine the coagulation and fibrinolytic activities in the blood.
  • APTT is reduced and D-dimer values significantly increased after intense exercise.
  • CONCLUSION: Our results indicate that exercise whether leisure or strenuous affects leukocytosis and hemostasis in both genders.
  • A major advantage of this study is the high numbers of individuals involved and the inclusion of both females and males values.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24520541.001).
  • [ISSN] 2220-315X
  • [Journal-full-title] World journal of experimental medicine
  • [ISO-abbreviation] World J Exp Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC3905589
  • [Keywords] NOTNLM ; Activated partial thromboplastin time / D-dimer / Exercise / Leukocytosis
  •  go-up   go-down


42. |||||..... 46%  Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T: Ultrasonography for leukocytosis or elevated C-reactive protein. Hepatogastroenterology; 2011 Jul-Aug;58(109):1156-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ultrasonography for leukocytosis or elevated C-reactive protein.
  • BACKGROUND/AIMS: Patients with abdominal symptoms and leukocytosis or elevated C-reactive protein were subjected to abdominal ultrasonography (US) for correct diagnosis.
  • METHODOLOGY: Patients with abdominal symptoms, leukocytosis and elevated C-reactive protein were enrolled.
  • Those with abnormal liver enzymes or radiographs were excluded since either of them might be a clue to proper diagnosis, such as hepatobiliary diseases or bowel obstruction.
  • RESULTS: Total number of patients was 38.
  • Number of acute diverticulitis, colitis, acute appendicitis and enteritis were 8, 7, 7 and 6, respectively.
  • Colon cancers were confirmed and pelvis tumor was diagnosed as ovarian squamous cell carcinoma with surgical specimens.
  • CONCLUSIONS: Our data clearly recommended that abdominal US be performed carefully for patients with abdominal symptoms and leukocytosis or elevated CRP since potentially they had malignancies.
  • [MeSH-major] Abdomen / ultrasonography. C-Reactive Protein / analysis. Leukocytosis / ultrasonography

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21937369.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 9007-41-4 / C-Reactive Protein
  •  go-up   go-down


43. |||||..... 46%  So KA, Hong JH, Jin HM, Kim JW, Song JY, Lee JK, Lee NW: The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study. Gynecol Oncol; 2014 Mar;132(3):551-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: a retrospective cohort study.
  • OBJECTIVE: Preoperative leukocytosis is known to be a negative prognostic factor for several gynecologic malignancies, but its relationship with epithelial ovarian carcinoma (EOC) is unknown.
  • We sought to evaluate the prognostic implications of preoperative leukocytosis for women with EOC.
  • Associations between leukocytosis and recurrence-free survival (RFS) and overall survival (OS) were determined by univariate analyses.
  • RESULTS: Of 155 women, 23 (14.8%) had leukocytosis and 132 (85.2%) did not have leukocytosis.
  • RFS and OS were significantly shorter for women with leukocytosis than for women without leukocytosis (P=0.009 and P<0.0001, respectively).
  • The mortality rate was also higher among women with leukocytosis (P<0.0001).
  • Multivariate analysis revealed that preoperative leukocytosis (hazard ratio [HR]: 2.15; 95% confidence interval [CI]: 1.55-4.41; P=0.009), advanced stage (HR: 3.12; 95% CI: 1.44-6.75; P=0.004), and optimal cytoreduction (HR: 0.38; 95% CI: 0.14-0.70; P=0.031) were independent prognostic factors for RFS.
  • Additionally, preoperative leukocytosis was independently associated with decreased OS (HR: 7.66; 95% CI: 2.78-21.16; P<0.0001).
  • CONCLUSIONS: Among women with EOC, preoperative leukocytosis might be an independent prognostic factor for RFS and OS.
  • [MeSH-major] Leukocytosis / pathology. Neoplasms, Glandular and Epithelial / pathology. Ovarian Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Carboplatin / administration & dosage. Cohort Studies. Disease-Free Survival. Female. Humans. Middle Aged. Neoplasm Staging. Paclitaxel / administration & dosage. Predictive Value of Tests. Preoperative Period. Proportional Hazards Models. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • HSDB. structure - TAXOL.
  • HSDB. structure - CARBOPLATIN.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2014 Elsevier Inc. All rights reserved.
  • (PMID = 24440470.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 33069-62-4 / Paclitaxel; BG3F62OND5 / Carboplatin; Ovarian epithelial cancer
  • [Keywords] NOTNLM ; Leukocytosis / Ovarian cancer / Overall survival / Recurrence-free survival
  •  go-up   go-down


44. |||||..... 46%  Nikanfar M, Shaafi S, Hashemilar M, Oskouii DS, Goldust M: Evaluating role of leukocytosis and high sedimentation rate as prognostic factors in acute ischemic cerebral strokes. Pak J Biol Sci; 2012 Apr 15;15(8):386-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluating role of leukocytosis and high sedimentation rate as prognostic factors in acute ischemic cerebral strokes.
  • Leukocytosis and increased Erythrocyte Sedimentation Rate (ESR) during the early phases of acute ischemic stroke has been proposed to be related with poor prognosis.
  • The White Blood Cell (WBC) count and ESR were determined on admitting and after 3 days.
  • Any history of Diabetes Mellitus (DM), Hypertension (HTN), Heart Disease (HD), Hyperlipidemia (HLP), smoking, CT scan findings, level of consciousness and the condition of patient on admission and discharge (according to Rankin's scale) were assessed.
  • Leukocytosis on day one was significantly more prevalent in patients passed away during hospitalization or discharged in not-so-well condition.
  • High WBC and ESR levels, altered consciousness, diffused lesions in CT scan and imperfect neurological condition on day one, as well as positive history of DM and HTN were significantly related with higher in-hospital death rate and/or poor condition at discharge.
  • Raised WBC count and ESR just after an ischemic stroke attack might be related with a poor prognosis and necessitate immediate and meticulous monitoring and therapies.
  • [MeSH-major] Brain Ischemia / physiopathology. Leukocytosis / physiopathology. Stroke / physiopathology

  • MedlinePlus Health Information. consumer health - Stroke.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24199468.001).
  • [ISSN] 1028-8880
  • [Journal-full-title] Pakistan journal of biological sciences: PJBS
  • [ISO-abbreviation] Pak. J. Biol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


45. |||||..... 45%  Kumar AD, Boehme AK, Siegler JE, Gillette M, Albright KC, Martin-Schild S: Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes. J Stroke Cerebrovasc Dis; 2013 Oct;22(7):e111-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes.
  • BACKGROUND: Neurologic deterioration (ND) after acute ischemic stroke (AIS) has been shown to result in poor outcomes.
  • ND is thought to arise from penumbral excitotoxic cell death caused in part by leukocytic infiltration.
  • Elevated admission peripheral leukocyte levels are associated with poor outcomes in stroke patients who suffer ND, but little is known about the dynamic changes that occur in leukocyte counts around the time of ND.
  • We sought to determine if peripheral leukocyte levels in the days surrounding ND are correlated with poor outcomes.
  • Demographics, daily leukocyte counts, and poor functional outcome (modified Rankin Scale score 3-6) were investigated.
  • Patients with a poor functional outcome had significantly higher leukocyte and neutrophil levels 1 day before ND (P = .048 and P = .026, respectively), and on the day of ND (P = .013 and P = .007, respectively), compared to patients with good functional outcome.
  • CONCLUSIONS: Leukocytosis at the time of ND correlates with poor functional outcomes and may represent a marker of greater cerebral damage through increased parenchymal inflammation.
  • [MeSH-major] Brain Ischemia / complications. Leukocytosis / complications. Stroke / complications

  • Genetic Alliance. consumer health - Ischemic stroke.
  • MedlinePlus Health Information. consumer health - Stroke.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2013 National Stroke Association. Published by Elsevier Inc. All rights reserved.
  • (PMID = 23031742.001).
  • [ISSN] 1532-8511
  • [Journal-full-title] Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
  • [ISO-abbreviation] J Stroke Cerebrovasc Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Deterioration / National Institutes of Health Stroke Scale / leukocytosis / outcome / prognosis / stroke
  •  go-up   go-down


46. |||||..... 45%  Sun W, Peacock A, Becker J, Phillips-Bute B, Laskowitz DT, James ML: Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage. J Clin Neurosci; 2012 Aug;19(8):1096-100
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage.
  • Intracerebral hemorrhage (ICH) is a devastating and common admitting diagnosis to intensive care units in the USA.
  • Using the Duke University Hospital Neuroscience Critical Care Unit Database, we retrospectively identified patients with an admitting diagnosis of supratentorial ICH from January to December 2010, verified by CT imaging.
  • ICH score, presence of midline shift on imaging, and white blood cell (WBC) count were used in a regression model for predicting END.
  • WBC count demonstrated the greatest association with END.
  • Elevated WBC count appears predictive of deterioration.
  • [MeSH-major] Cerebral Hemorrhage / complications. Leukocytosis / etiology. Nervous System Diseases / etiology. Statistics as Topic
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Analysis of Variance. Female. Glasgow Coma Scale. Humans. Leukocyte Count. Male. Middle Aged. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Health Statistics.
  • MedlinePlus Health Information. consumer health - Neurologic Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2012 Elsevier Ltd. All rights reserved.
  • [Cites] J Stroke Cerebrovasc Dis. 2009 Mar-Apr;18(2):144-9 [19251191.001]
  • [Cites] Neurosurgery. 2009 Mar;64(3):436-45; discussion 445-6 [19240605.001]
  • [Cites] Int J Qual Health Care. 2009 Dec;21(6):441-7 [19828550.001]
  • [Cites] Stroke. 2010 Jan;41(1):54-60 [19910545.001]
  • [Cites] J Neurotrauma. 2010 Jan;27(1):217-28 [19803787.001]
  • [Cites] J Clin Neurosci. 2010 Nov;17(11):1367-71 [20692165.001]
  • [Cites] World Neurosurg. 2010 Jun;73(6):654-67 [20934153.001]
  • [Cites] Neurosurgery. 2010 Nov;67(5):1243-51; discussion 1252 [20948399.001]
  • [Cites] Ann Neurol. 2011 Feb;69(2):389-99 [21387381.001]
  • [Cites] J Neurol. 2011 Apr;258(4):634-40 [21057958.001]
  • [Cites] Biomarkers. 2009 Sep;14(6):388-94 [19505208.001]
  • [Cites] Stroke. 2001 Apr;32(4):891-7 [11283388.001]
  • [Cites] Neurosurgery. 2002 Nov;51(5):1128-34; discussion 1134-5 [12383357.001]
  • [Cites] Stroke. 2003 Jul;34(7):1717-22 [12805488.001]
  • [Cites] Neurology. 2004 Aug 10;63(3):461-7 [15304576.001]
  • [Cites] Stroke. 1985 Mar-Apr;16(2):251-5 [3975963.001]
  • [Cites] Neurology. 1994 Aug;44(8):1379-84 [8058133.001]
  • [Cites] Stroke. 1996 Aug;27(8):1304-5 [8711791.001]
  • [Cites] Stroke. 1997 Jan;28(1):1-5 [8996478.001]
  • [Cites] J Cereb Blood Flow Metab. 1997 Nov;17(11):1210-20 [9390653.001]
  • [Cites] QJM. 2006 Sep;99(9):625-33 [16905751.001]
  • [Cites] Stroke. 2007 May;38(5):1641-4 [17379820.001]
  • [Cites] Neurology. 2007 May 15;68(20):1651-7 [17502545.001]
  • [Cites] Stroke. 2007 Jun;38(6):2001-23 [17478736.001]
  • [Cites] Stroke. 2008 Aug;39(8):2304-9 [18556582.001]
  • [Cites] Stroke. 2009 Feb;40(2):632-9 [19109539.001]
  • (PMID = 22704946.001).
  • [ISSN] 1532-2653
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Grant] United States / FIC NIH HHS / TW / D43 TW008303; United States / FIC NIH HHS / TW / D43-TW008308-01; United States / NINDS NIH HHS / NS / L30 NS071908
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Scotland
  • [Other-IDs] NLM/ NIHMS387789; NLM/ PMC3706635
  •  go-up   go-down


47. ||||...... 45%  Pilger D, Heukelbach J, Diederichs A, Schlosser B, Pereira Leite Costa Araújo C, Keysers A, Liesenfeld O, Feldmeier H: Anemia, leukocytosis and eosinophilia in a resource-poor population with helmintho-ectoparasitic coinfection. J Infect Dev Ctries; 2011 Apr;5(4):260-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anemia, leukocytosis and eosinophilia in a resource-poor population with helmintho-ectoparasitic coinfection.
  • Stool and blood samples were collected and individuals were clinically examined for the presence of ectoparasites.
  • Leukocytosis was found in 13%, eosinophilia in 74%, and hypereosinophilia in 44% of the participants.
  • Our study confirms in a population with high prevalence of intestinal helminthiases and ectoparasites that eosinophilia can be used to accurately diagnose current parasitic infection and initiate treatment.
  • [MeSH-major] Anemia / epidemiology. Ectoparasitic Infestations / complications. Ectoparasitic Infestations / epidemiology. Eosinophilia / epidemiology. Helminthiasis / complications. Helminthiasis / epidemiology. Leukocytosis / epidemiology

  • Genetic Alliance. consumer health - Anemia.
  • MedlinePlus Health Information. consumer health - Anemia.
  • MedlinePlus Health Information. consumer health - Eosinophilic Disorders.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21537067.001).
  • [ISSN] 1972-2680
  • [Journal-full-title] Journal of infection in developing countries
  • [ISO-abbreviation] J Infect Dev Ctries
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  •  go-up   go-down


48. ||||...... 45%  Deibener-Kaminsky J, Lesesve JF, Grosset S, Pruna L, Schmall-Laurain MC, Benetos A, Kaminsky P: [Clinical relevance of leukocyte differential in patients with marked leukocytosis in the emergency room]. Rev Med Interne; 2011 Jul;32(7):406-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical relevance of leukocyte differential in patients with marked leukocytosis in the emergency room].
  • [Transliterated title] Signification d'une hyperleucocytose marquée et de la formule sanguine dans les situations d'urgence.
  • PURPOSE: We analyzed the characteristics of the leukocyte differential and the clinical outcome in patients admitted in an emergency department with marked leukocytosis greater than 20×10(9)G/L.
  • Admission in intensive care unit (ICU), consciousness impairment or death defined the subgroup S of high severity.
  • Leukocyte and neutrophil counts were significantly higher and basophil count significantly lower in subgroup S.
  • CONCLUSION: Marked leukocytosis indicated severe illness.
  • [MeSH-major] Emergency Service, Hospital. Leukocytosis / mortality

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.
  • (PMID = 21292359.001).
  • [ISSN] 1768-3122
  • [Journal-full-title] La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne
  • [ISO-abbreviation] Rev Med Interne
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


49. ||||...... 45%  Nidimusili AJ, Alraies MC, Eisa N, Alraiyes AH, Shaheen K: Leukocytosis of unknown origin: gangrenous cholecystitis. Case Rep Med; 2013;2013:418014
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukocytosis of unknown origin: gangrenous cholecystitis.
  • The current case is unique, since our patient denied any prior episodes of abdominal pain and the only tip off was leukocytosis.
  • A high index of suspicion is essential for the early diagnosis and treatment of GC.
  • The radiological investigations may not be conclusive.
  • There is a need for an early (if not urgent) surgical intervention in acute cholecystitis (whether laparoscopic or open surgery) in order to decrease the time elapsed from the start of symptoms to admission and treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23606852.001).
  • [ISSN] 1687-9627
  • [Journal-full-title] Case reports in medicine
  • [ISO-abbreviation] Case Rep Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3628491
  •  go-up   go-down


50. ||||...... 45%  Caramazza D, Caracciolo C, Barone R, Malato A, Saccullo G, Cigna V, Berretta S, Schinocca L, Quintini G, Abbadessa V, Di Raimondo F, Siragusa S: Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms. Ann Hematol; 2009 Oct;88(10):967-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms.
  • The evidence that leukocytes may contribute to the pathogenesis of thrombosis in Chronic Myeloproliferative Neoplasms is increasing but not definitive.
  • To further enforces whether an increased leukocyte count is associated with thrombosis and whether this effect can be modulated by cytoreductive therapy, we analyzed the clinical course of 187 patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET) followed at two Italian Institutions over a period of 7 years.
  • The association was measured at diagnosis or before thrombotic events: a multivariable analysis was carried out using data at baseline and time-dependent covariates.
  • We found that white blood cells (WBC) count above 9.5 x 10(9)/L at diagnosis (baseline analysis) was associated with thrombosis during the follow-up (Hazard Ratio [HR] of 1.8, p 0.03).
  • At the time-dependent analysis, therapy with hydroxyurea (HU), lowering by 35% the baseline WBC level, reduced such strength of association giving a HR of 1.3 (p value non significant).
  • We found a trend between WBC level and thrombosis in untreated low-risk patients (RR of 1.9, 95% CI 0.9 to 3.1); in high-risk patients treated with HU this correlation was clearly lost (RR 1.1, 95% CI 0.2 to 2.7).
  • Finally, we could not identify the presence of JAK2 (V617F) as a risk factor for thrombosis.
  • [MeSH-major] Leukocytosis / complications. Polycythemia Vera / complications. Thrombocythemia, Essential / complications. Thrombosis / etiology
  • [MeSH-minor] Aged. Female. Humans. Hydroxyurea / pharmacology. Hydroxyurea / therapeutic use. Janus Kinase 2 / genetics. Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / complications. Leukocyte Count. Male. Middle Aged. Multivariate Analysis

  • Genetic Alliance. consumer health - Thrombosis.
  • HSDB. structure - HYDROXYUREA.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19214510.001).
  • [ISSN] 1432-0584
  • [Journal-full-title] Annals of hematology
  • [ISO-abbreviation] Ann. Hematol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Germany
  • [Chemical-registry-number] EC 2.7.10.2 / JAK2 protein, human; EC 2.7.10.2 / Janus Kinase 2; X6Q56QN5QC / Hydroxyurea
  •  go-up   go-down


top


2. Definitions


3. Related RMF webpages


terms of use | advertising programs | contact us
© 2014 RecentMedicalFindings


Connect with the


RMF


audience;




Post your ad here!